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Abstract
Today’s methadone patients differ from those of the past due to increases in polydrug
use, mental health issues, and medical needs. Patients requiring methadone treatment for
their opiate addiction are now older than those who initially presented for treatment when
methadone treatment first started. The number of older opiate users will continue to grow
as the population continues to age. Although previous studies on opiate addiction focused
on using methadone in treatment of younger adults, this study used phenomenological
methodology to explore the lived experiences of opiate addicted methadone users
between the ages of 50 to 55, an understudied population. A sample of 8 older addicts from
the Midwest, using methadone in their treatment, provided data collected in face-to-face
interviews for this study. Content analysis of the data was conducted with the assistance of

NVivo 11 to code and identify categories and themes. Emergent themes included: the
impact of methadone use on participants’ relationship with others, participants’ attitude
of being an older methadone user, mental health stressors related to being an older
methadone user, struggles in attending the methadone clinic daily, and needing other
treatment besides treatment for methadone use. The study impacts social change by
informing addiction professionals who may want to develop appropriate treatment
interventions for this population.
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Chapter 1: Introduction to the Study
Drug addiction is increasing in the United States. According to the National
Institute on Drug Abuse (2011), in 2010 more than 23,000,000 Americans age 12 years
and older had used some type of illicit drug or abused psychotherapeutic medication.
According to the Substance Abuse and Mental Health Services Administration
(SAMHSA, 2014), illicit drug use in older adults increased 3.4% in 2002 to 7.9% in
2013. Among individuals ages 55–59 years, the rate of current illicit drug use increased
from 1.9% in 2002 to 5.7% in 2013. Among individuals ages 60–64 years, the rate of
current illicit drug use increased from 1.1% in 2003 and 2004 to 3.9% in 2013
(SAMHSA, 2014).
Opiate dependency is becoming a major issue. From 2000 to 2010, opiate use and
dependency nearly tripled (SAMHSA, 2011). Among people ages 50–59 years, the rate
of illicit drug use including opiates went from 2.7% in 2002 to 5.8% in 2010 (SAMHSA,
2011). This increase also reflects more people with an opiate addiction seeking treatment.
Treatment admission for opiate-addicted clients increased 271% between 1995 and 2005
(SAMHSA, 2011). Figure 1 illustrates the increase of opiate use among older adults over
a 10-year period.
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Figure 1. Opiate users by age, 2002–2012. Adapted from Results From the 2013 National
Survey on Drug Use and Health: Summary of National Findings, by the Substance Abuse
and Mental Health Services Administration, 2013, p. 24. Copyright 2014 by the
Substance Abuse and Mental Health Services Administration.
Many people who were addicted to drugs and alcohol are now experiencing
successful abstinence from their addiction and are living a life of recovery. According to
a 2007 study by National Institute on Drug Abuse, there was an 86% abstinence rate after
3 years of recovery (National Institute on Drug Abuse, 2011). Previous research
regarding addiction has shown that opiate addicts continue to use substances long after
being involved in treatment despite the high death rate associated with opiate use
(Scherbaum & Specka, 2008). However, there is a positive correlation between
individuals taking methadone and staying in treatment. This correlation is attributed to
the need for long-term management for opiate addiction (Bart, 2012).
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The concept of recovery is sometimes unclear and difficult to define. T. McLellan
(2012) indicated that many people, professionals, and laypersons use the term recovery,
but there is no standard definition for the term. T. McLellan noted that in 2006, the Betty
Ford Institute presented a working definition for recovery in order to dialogue about its
meaning. The institute defined recovery as “A voluntarily maintained lifestyle comprised
of sobriety, personal health, and citizenship” (Betty Ford Institute, as cited in T.
McLellan, 2010, p. 137). This definition was consistent with experts who also saw
recovery in the same manner (Belleau et al., 2007).
Others have indicated that in order for addicts to be successful in their recovery,
they must be abstinent from their drug of choice for at least 2 years (Del Toro, Thom,
Beam, & Horst, 1996). Recovery is seen as the primary reason for treatment in most
behavioral health care policies (Institute of Medicine, 2006). This is especially true when
examining government-funded service initiatives, such as the Center for Substance Abuse
Treatment’s Community Support Program and Access to Recovery Program, as well as
community programs that work to develop recovery-oriented care (White, 2009).
Individuals who are involved in recovery often need additional support such as a 12-step
program or a relationship with a higher power (Laudet, 2007). De Maeyer et al. (2011)
concluded that it was important to support opiate-addicted individuals in their daily lives
by providing them practical, social, and environmental support in addition to their
methadone use to improve their quality of life.
Methadone treatment dates back more than half a century, and programs for
methadone clients are seeing people older than ever before (Marion, 2005). Using a small
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clinical trial to demonstrate methadone’s effectiveness, Dole and Nyswadner developed a
new approach to opiate addiction treatment (as cited in Kuehn, 2005). Their research
suggested that doctors could use medications to help control addicts’ cravings and
withdrawal, which often led to relapse in individuals with opioid addiction. Their work
began to give credence to the idea that opioid addiction is a chronic disease, similar to
diabetes, requiring long-term treatment. Methadone is the primary medication for treating
heroin addiction (Mattick, Breen, Kimber, & Davoli, 2009). Addicts are given a daily
dosage of methadone as it remains operational in their system for 24 hours, blocking
heroin’s euphoric properties (Jaffe, 1990). Methadone continues to be the most accepted
treatment for opiate addiction. Under the supervision of trained medical professionals,
methadone has been shown to provide effective treatment for people addicted to opiates
(Amato et al., 2005).
Although several countries use methadone for treating opioid dependence, there
has been some discussion about its effectiveness. Methadone helps opiate addicts reduce
their withdrawal symptoms and has been seen as a lifesaver for many people (Bart,
2012). However, it is not an addiction cure-all. Research has shown that some addicts use
other addicting drugs such as cocaine and benzodiazepines while engaging in other
disruptive behaviors that affect their treatment (Kleber, 2008). Keys (2008) noted that
there has been significant debate about the reasons addicts continue to use opiates and
indicated that addicts seek a feeling of euphoria or they are trying to avoid the pains of
withdrawal. When opiate addicts fail to complete treatment or have a negative attitude
about methadone, they are at higher risk of relapse (Keys, 2008). Gossop, Stewart,
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Browne, and Marsden (2002) studied relapse involving heroin users and learned that
addicts who failed to complete treatment or had a negative attitude about methadone were
at a greater risk of relapse than those who were successful in treatment.
In their study on addiction, Stephens, Roffman, Fearer, Williams, and Burke,
(2007) noted that one reason for people not seeking treatment was that they were not
ready to stop using their drug of choice. Orr-Brown and Sibert (2007) noted that if child
welfare or other systems order people into treatment, they are resistant to treatment if
they do not want to change. Collins and Slesnick’s (2011) study on motivation for
discontinuation showed that people were reluctant to change despite the consequences of
their continued usage. Methadone has been the most studied treatment modality for
opiate dependency, and previous studies have shown it has been effective (Clausen,
Anchersen, & Waal, 2008; Degenhardt et al., 2011; Mattick et al., 2009). However,
research and treatment recommendations regarding methadone treatment for individuals
age 50 and older are lacking. Although the literature review conducted for the present
study revealed that many researchers have studied methadone treatment as well as
addiction and its impact on society and families, I found little about methadone use and
older adults. Without this information, human service professionals cannot adequately
meet the needs of older individuals on methadone.
Purpose of the Study
The purpose of the present study was to assess the relationship between
methadone maintenance and the life experiences of opiate users ages 50–55 years. I
examined an underserved area in opiate addiction that also reflects an aging population.

6
Ten percent of people involved in some type of methadone treatment are age 50 years or
older (Gossop & Moos, 2008). As methadone users age, treatment providers and others
may need to review the physical and mental health and the continued illegal drug use
among this population. Further, results from this present study can be used to help
treatment providers determine the best modalities for helping opiate-dependent clients,
particularly older opiate addicts who seek assistance in treating their addiction to opiates
and other drugs.
Research on methadone treatment and substance abuse among the identified
population may help change the negative stigma associated with older addicts.
Understanding the interconnectedness of older addicts’ needs is necessary for providing
adequate care for this particular population. Researchers, legislators, and treatment
providers may benefit by understanding the lived experiences of older opiate addicts.
With the changes in methadone practices and policies over the years, research on this
particular population may provide some clarity on the impacts these changes will have on
continued methadone use.
Significance of the Study
There continues to be a significant gap in the treatment of addiction in the United
States. As previously stated, 23,000,000 Americans acknowledge a need for treatment,
but only 2,5000,000 addicts receive treatment (National Institute on Drug Abuse, 2011).
Older adults in the United States consume over one third of all prescriptions drugs, which
may place them at risk for developing a substance abuse problem (Gossop & Moos,
2008). Greater rates of lifetime drug use among older drug users combined with increases
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in the aging population suggest that there will be a growing number of older people who
may misuse or abuse drugs. Older opiate addicts, who began using early in their lives, are
now aging and are changing the demographics of people needing substance abuse
treatment (Rosen, Smith, & Reynolds, 2008). Reported drug use among older adults
places greater demands on treatment programs (Ayres, Eveson, Ingram, & Telfer, 2012).
Given the indications of increased drug use by older drug users, there needs to be a way
to monitor the impact their drug use has on their lives and their communities. Research
has shown that there is a major difference between people who receive therapy before age
25 years and those who first come into treatment at a much older age (Chi et al., 2014).
Methadone treatment programs are now working with older individuals who also
present themselves with other significant problems such as complex health issues,
transportation issues, and financial issues (Doukas, 2011). Methadone’s ability to
decrease early deaths in opiate addicts has caused some people to stay on methadone for
years (Doukas, 2011). Given the small amount of research specific to older methadone
users, the present study’s focus was on examining their lives and understanding what it
means to be an older addict dependent on methadone. I examined the lived experiences of
older adults on methadone to help treatment providers meet the needs of this growing
population.
Little research exists regarding this population; therefore, this study is important
to the addiction field as it increased the understanding of older opiate users and their
specific variables such as family, medical and legal issues, and other relationships. Study
findings can help promote changes through improved understanding of methadone use
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among older adults. Study results can help inform substance abuse therapists and future
areas of research. It was my hope to further the understanding of what is happening with
this population and how society reacts to older people addicted to opiates.
Problem Statement
Studies have shown that heroin addicts who do not use methadone have a greater
chance of relapsing or dying due to their drug use (Bell, Trinh, Butler, Randall, & Rubin,
2009). With the exception of addicts who quit treatment in the beginning of their
methadone therapy, those who stayed in treatment were able to maintain their sobriety
longer than those who failed to use methadone (Bell, Trinh, et al., 2009). Although
methadone has successfully been used as a major therapy tool for people addicted to
different opiates, some questions remain regarding its long-term use (Ducharme,
Knudsen, & Roman, 2006). Though relapse occurs for people addicted to alcohol and
other drugs, opiate addicts are more likely to relapse than those addicted to other illegal
drugs and alcohol (Marissen et al. 2006). In researching the literature regarding opiate
use, I did not find much information regarding long-term methadone use in the older
population.
With the increase in dependency on prescription pain medications, as well as the
increase on other pharmacological remedies for addiction, additional treatment methods
are needed to address long-term recovery for opiate users, particularly older opiate users.
Doukas (2011) noted that as methadone treatment has entered its sixth decade, programs
that provide services to this population are now treating clients who are in their 50s, 60s,
and 70s.
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Research Questions
The present study’s focus was on understanding the lives of older people addicted
to opiates using methadone treatment to overcome their addiction. Two research
questions were formulated to guide this inquiry. First, what are the lived experiences of
opiate users ages 50–55 years who take methadone to manage their addiction? A followup question was how do these same individuals remain consistent in their methadone
treatment so that they can stay in recovery? Second, how do opiate user ages 50–55 years
relate their particular experiences to the idea of recovery?
Conceptual Framework
The primary theoretical framework in this study was from Beck, Wright, Newman
and Liese (1993), who developed a treatment modality for addicts using cognitive
behavioral therapy (CBT). According to Pascoe (2008), the combination of behavioral
and cognitive therapy created CBT. CBT is a psychotherapeutic approach that works to
change clients’ behaviors by having them develop specific goals to meet their needs (A.
C. Butler, Chapman, Forman, & Beck, 2006; Epstein, Hawkins, Covi, Umbricht, &
Preston, 2003; Shah, Scogin, Presnell, Morthland, & Kaufman, 2013). CBT is not one
specific approach to therapy but includes several approaches that share similar theoretical
frameworks (MacLaren, 2008). These frameworks involve a variety of methods and
therapeutic systems such as rational emotional behavioral therapy, cognitive therapy, and
behavioral activation (Dobson & Dozois 2001).
Therapists use CBT to treat a variety of problems including mood disorders,
anxiety, and eating disorders, as well as addiction (Cooper, 2008). When using CBT for
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addiction treatment, therapists view substance dependency as a learned behavior acquired
through experience (Pascoe, 2008). Therapists may use CBT in individual and group
therapy as self-help applications for relearning or changing peoples’ thought patterns,
emotions, and habits (Kadden, 2002).
CBT’s framework is based on the idea that people’s problems result from their
maladaptive or negative thinking that influences their emotions and behaviors (O’Donnell
& Cook, 2006). Conducting a study on CBT combined with methadone treatment,
Kouimtsidis, Reynolds, Coulton, and Drummond (2012) concluded that addicts who used
methadone and CBT gained coping skills that helped them remain abstinent after 12
months. Kouimtsidis et al noted that clients who underwent CBT increased their
problem-solving skills and sought alternatives to their drug use. Kouimtsidis et al.
showed results similar to a previous study on CBT in group therapy where addicts
showed improvement regarding drug use, employment, and other aspects of their lives
after 6 months (Scherbaum et al., 2005).
CBT does not immediately eliminate drug use, but based on the Addiction
Severity Index (ASI) this approach helps reduce their dependency over time (Epstein et
al., 2003). One of the reasons for the improvement of dependency over time is that CBT
focuses on present, not past behavior (O’Donnell & Cook, 2006). Using CBT for
substance abuse clients involves identifying such issues as the severity of their addiction,
the extent of their problems, their motivation for change, and the therapeutic relationship
(McCrady, 2001). CBT further involves helping the client engage in self-monitoring and
honesty as it relates to any drug use, including the amount consumed and the regularity of
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use. Working with addicts over time will help them identify and eliminate other triggers
that lead to drug use and abuse.
Therapists should encourage CBT clients to make changes based on their thoughts
and belief systems. As clients’ belief systems help them achieve their goals, therapists
should not dictate who the clients are or how they should be. CBT can help addicts cope
with life more effectively by learning and relearning the way they think, feel and behave,
which is consistent with how they want people to see them (Pascoe, 2008).
Harm reduction has been one of the most influential ideas influencing drug
treatment policies since the early 1980s (McKeganey, 2011). The idea of harm reduction
began in the 1970s when Sobell and Sobell (1976) endorsed previous research that
indicated some addicts were able to control their drinking after completing treatment.
Methadone as a tool for harm reduction has been used in European countries since the
late 1960s (Jarvinen, 2008). Early treatment in Europe was similar to that in the United
States in which abstinence was the only goal for any drug regardless of what the addict
wanted. The prevailing view in the United States has long been against any type of
maintenance and has held methadone treatment as the addict continuing to engage in drug
use (Drucker & Clear, 1999). Some drug courts have insisted that defendants on
methadone reduce their usage or agree to become totally abstinent (Csete & Catania,
2013). This position has given way to methadone treatment being stigmatized and
misunderstood. Methadone treatment needs to become a standard psychopharmacological
treatment for heroin dependence and an important tool in harm reduction.
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Nature of the Study
The nature of this study was qualitative, which involved collecting data by
interviewing methadone maintenance clients ages 50–55 years involved in a methadone
clinic for at least 2 years, and who had been sober for at least 1 year. In addition, I
conducted interviews with clients and gathered information regarding their history of use,
relapses, length of time on methadone, any relapses while using methadone, and other
treatment modalities they had used while taking methadone. Interviewing these clients
provided information regarding how they perceive their lived experiences, addiction, and
treatment experiences. The population I researched came from methadone programs in
West Michigan. These programs have a large methadone population to choose from
which allowed me to use a hermeneutic phenomenological approach in which
participants described their experiences that I interpreted to understand their experiences
on methadone and its significance in their lives.
Definitions
Addiction Severity Index: The Addiction Severity Index (ASI) is a tool used in the
field of addiction. Clinicians interview potential clients and gather information covering
seven specific areas in their lives: legal, employment, relationship, alcohol, drug,
psychiatric, and medical (Alterman et al., 1998; S. F. Butler et al., 1998). These seven
areas serve as a rational inductive basis for the ASI items and their aggregation into
scales (McLellan et al., 1992). The ASI can cover a person’s lifetime. However, the
interviewer summarizes each of the fields using the composite scores for the addicts’
previous 30 days to assess their problems levels when they are ready to enter treatment
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(Bovasso, Alterman, Cacciola, & Cook, 2001). The ASI is seen as reliable, valid, and
consistent from intake to follow-up regardless of gender, age, race, or drug of choice.
American Society of Addiction Medicine: The American Society of Addiction
Medicine (ASAM) is an organization for physicians with a focus on addiction and its
treatment. The ASAM criteria are a broad set of strategies therapists use to place
addiction clients in treatment and to discharge them (Kosanke, Magura, Staines, Foote, &
Deluca, 2002). The ASAM criteria, also known as the ASAM patient placement criteria,
are the most renowned professionally developed guidelines for ensuring addicts are
placed in the correct level of care (Hays, 2006; Magura et al., 2003; Mee-Lee, 2013). The
criteria allow therapists and others to evaluate and determine the severity of the client’s
needs based on the six dimensions (Hays, 2006). The criteria are used for placing people
with addiction in the level of treatment needed for recovery. In addition, therapists use
the ASAM as a guideline for addicts continued stay or transfer to a lower level of care.
Antagonists: Opioid antagonists reduce the rate of relapse in clinical trials and
reduce reinstatement in animal models of drug seeking (Perry & McNally, 2013). Using
different antagonists helps limits overdosing and provides safety for the opiate users
(Bickel & Amass, 1995). Antagonists also work for opiate-dependent clients. According
to Carrol, Walsh, Bigelow, Preston, and Strain (2006), Tramadol has been used as an
antagonist for opiate users. Tramadol has been marketed for approximately 50 years and
has not shown to have abusive tendencies (Woody et al., 2003).
Co-occurring: Co-occurring refers to the treatment of both substance abuse and
mental health disorders (Shively, 2008; SAMHSA, 2005). Chambers (2008) defined co-
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occurring as individuals who are diagnosed with a mental illness and substance abuse;
however co-occurring is different from a dual diagnosis, which could indicate having
more than one mental health disorder. Chandler, Peters, Fields, and Juliano-Bult (2004)
used the terminology co-occurring disorders, co-morbidity, dual disorders, and dual
diagnosis when a person was involved in the criminal justice and other systems (p. 433).
Although there continues to be no universal agreement on how to treat clients with cooccurring disorders, Minkoff and Cline (2006) argued that co-occurring disorder should
be seen as the expectation not the exception.
Disease model: The disease model of addiction is supported in the United States.
The disease model uses medical language to frame how people think of addiction in
general (Shaffer, 1991). Thinking of addiction as a disease provides therapists a way of
working with addicts by removing the notion of perspective treatment in addition to
eliminating the therapists being too empathic to the problems (Margulies, 1989). Shaffer
(1991) indicated that the disease model works with programs that encourage abstinence,
but accept the idea that addicts will slip while in recovery. The disease model indicates
that addicts have physiological differences from nonaddicts, and the reason for this could
be genetic (Shaffer, 1991). Based on the disease model, addiction cannot be cured as
addicts will be in a constant state of recovery.
Medication-assisted treatment (MAT): This approach has been available for
treating alcohol and opiate use for some time. It is important in improving the health of
opiate-dependent clients (Bruce, Kresina, & McCance-Katz, 2010). MAT treatment
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providers have understood the use of MAT is as an important tool for treating addiction
(Kelch, & Piazza, 2011).
MAT’s function is to serve as a platform on which a recovery lifestyle can be
built. Although MAT treatment reduces harm and physically stabilizes those who
participate, it does not guarantee abstinence or guarantee being socially responsible
(Rabinowitz, 2009). Although it continues to be a topic of debate in the United States, in
other countries people using methadone are thought of as being in a MAT program
(Laudet, 2007). MAT has been shown to improve opiate users’ lives by reducing the
impact of addiction on their families and the community. Ginter (2012) noted MAT
participants benefit from being involved in recovery groups and that it is important for
recovery groups to support MAT’s use.
Recovery groups: Recovery groups are self-help groups of people who
acknowledge having similar problems and try to help each other work through their
problems (Flora, Raftopoulos, & Pontikes, 2010). Self-help groups have grown
significantly, particularly Alcoholics Anonymous (AA) and Narcotics Anonymous (NA).
Using AA or NA as part of an addict’s aftercare treatment has demonstrated decreases in
relapses and increases in abstinence from drugs or alcohol (Gossop, Stewart, & Marsden,
2008).
Addicts who are involved in recovery groups develop new relationships with
people who are also abstaining from drug use and learn new coping skills to avoid
relapse. One of the reasons people are involved in self-help groups is to identify with
recovery as opposed to being identified with addiction (Buckingham, Frings, & Albery,
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2013). B. S. Brown, O’Grady, Farrell, Flechner, and Nurco (2001) noted that older
addicts attended NA meetings more often than younger addicts and have a more serious
drug problem.
Others have indicated that AA’s and NA’s approach is not for everyone. Ellis and
Velten (1992) developed a self-help guide for people who wanted to stop drinking but did
not believe in AA. They concluded that the main reason people used drugs and alcohol
was due to their negative belief system in which they needed to develop strong goals and
find a way to achieve these goals. Others have questioned recovery groups’ effectiveness.
Peele, Bufe, and Brodsky (2000) argued the programs are not effective simply because
they are popular. From their perspective, people do not benefit from being involved in
AA or NA for a long period of time but rather from being motivated to make changes.
Visual Analogue Scale: The Visual Analog Scale (VAS) is a measure used in
research to determine pain intensity (Jensen, Chen, & Brugger, 2003). Researchers often
use the VAS as it does not require as much explanation for participants compared to other
measurements such as discrete scales (Reips & Funke, 2008). VAS is presented as a
horizontal line fixed with two extreme descriptors (Flynn, van Schaik, & van Wersch,
2004). Study participants who completed a survey using the VAS showed their
agreement on the continuous line between those two points. The VAS is different from a
Likert-type scale as the participants may respond to specific points on the scale. Savvas,
Somogyi, and White (2011) used the VAS to measure opiate addicts’ emotional reaction
to methadone use. Savvas et al. concluded that opiate addicts on methadone maintenance
appear to have less reaction to any mood induction during the peak of their methadone
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injection compared to nonaddicts who were in the study. This suggested that methadone
reduces elative and depressive emotional reactivity (Savvas et al., 2011).
Assumptions and Limitations
A major assumption in conducting a phenomenological study is that people will
understand this methodology. Although some researchers have embraced
phenomenological research for learning about people’s experiences, few are aware of the
structure involved in this research methodology (Giorgi, 2006). Another assumption was
that due to more multifaceted barriers, older methadone users may find it more difficult
to follow methadone treatment expectations as compared to their younger counterparts.
Three limitations were accepted regarding this study. First, phenomenological
studies need only a small number of participants. Therefore, the results cannot be
generalized to a larger population. Second, the success of any phenomenological study
depends on the competency of the participants who share their stories, and what the
researcher concludes (Valle & Mohs, 1998). A phenomenological study’s success also
depends on whom the researcher chooses to be involved in the study and these
individuals’ capacities for sharing the appropriate information. These limitations were
applicable to the present study. The third limitation was that I may have had a bias as a
nonaddict who is not in recovery. A variety of triangulation techniques were used in the
present study to limit my perspective’s potential impact. Triangulation is further
discussed in Chapter 3.
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Summary and Organization of the Study
The present study was intended to contribute to the literature regarding opiate
dependency, with an emphasis on methadone use among older opiate users. The present
study includes a definition of addiction, an examination of opiate user treatments, and a
review of the information specifically addressing methadone users ages 50–55 years.
Chapter 2 includes a comprehensive exploration of studies on methadone use,
opiate dependency, addiction, and lives of methadone users. I also identified specific
definitions and attempted to see them from the perspective of methadone users ages 50–
55 years. As such, each topic in this chapter was analyzed using a generalized and
comprehensive evaluation that focused specifically on addiction, opiates, methadone, and
relapse.
Chapter 3’s focus is on the present study’s design, including participant
enrollment procedures, informed consent procedures, and data collection methods. This
chapter also includes a detailed description of the interview process and questions that
were included in the interview as well as the analysis method.
Chapter 4 includes information on how the data were generated and how
participants were recruited. It also includes an account of the results and how participants
answered the research questions and aided in initiating the origin of a theory related to
opiate dependence and methadone use.
Chapter 5 completes the present study with a discussion of results, implications
for social change, recommendations, and conclusions. Chapter 5 also includes a review
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and explanation of the findings reported in Chapter 4 as well as discussion of my
experiences conducting this study.

20
Chapter 2: Literature Review
Research since the early 1980s has shown the high rate of relapse and mortality
for heroin users who are not involved in a methadone maintenance program (Bell,
Shearer, et al., 2009). Today’s methadone clients are different from previous methadone
users due to an increase in polydrug use (Doukas, 2011). There have been numerous
longitudinal studies on heroin users; some have noted that 30% of heroin users continue
to use in their old age (Hamilton & Grella, 2009).
The purpose of this literature review was to explore current research concerning
addiction, heroin, methadone use, and opiate dependency, specifically looking at opiate
users age 50 years and older. I gathered information on opiate addiction and also looked
at different ways to prevent relapse. Addicts ages 50 years and older who were diagnosed
with an opiate dependency were the focus. Few researchers have examined the lived
experienced of this population and their methadone experience.
Literature Search Strategy
I obtained literature through an online search at Walden University as well as
online research databases from Grand Valley State University and Western Michigan
University. The primary instrument used was EBSCOhost, which included PsycINFO,
PsycARTICLES, and SocINDEX. I used the following keywords to locate studies to
review: opiate, relapse, methadone maintenance, gender, mortality, age, and addiction. I
focused on journals specific to addiction such as Addiction, The American Journal of
Drug and Alcohol Abuse, and Substance Use and Misuse. I also identified additional
relevant articles by examining the reference lists of articles previously located.
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Introduction to the Literature Review
Research has shown that many addicts continue their drug use despite the possible
consequences of incarceration or death (Scherbaum & Specka, 2008). Society has often
overlooked or failed to report drug abuse in the elderly (McGrath, Crome & Crome,
2005). Widlitz and Marin (2002) called it the invisible epidemic due to the symptoms of
abuse in older adults not being reported as compared to their younger counterparts.
Although there is a wealth of information related to substance abuse, most researchers
have focused on either prevention or treatment from a youth to middle-aged perspective.
As a result, insufficient research regarding older adults and their addiction raises
questions regarding public policies for addressing substance abuse in this population.
Though society has considered addiction to illegal drugs a problem only young
people experience, addiction has no age limit. With an aging population in the United
States, more baby boomers who have acknowledged using or misusing drugs will need
treatment (Briggs, Magnus, Lassiter, Patterson, & Smith, 2011; Gfroere, Penne,
Pemberton, & Folsom, 2003). Entering their sixth decade for the treatment of opiate
addiction, older clients are coming into methadone treatment programs not only seriously
addicted to opiates but also with other major problems such as health issues (Anderson &
Levy, 2003; Doukas, 2011; Firoz & Carlson, 2004; Kwiatkowski & Booth, 2003). It is
important to determine how well these programs are meeting the needs of these clients
and identify any gaps in service.
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Definition of Dependency and/or Abuse
There are different definitions of addiction. Some describe addiction as a disease
state caused by the pharmacological outcomes of an incapacitating and ongoing drug use
(Larance, Degenhardt, Lintzeris, Winstock, & Mattick, 2011; Naliboff, Wu, & Pham,
2006; Sellman, 2010). Others define addiction as being compulsive and chronic with
relapse being possible despite abstinence for several years (Miller & Gold, 2007; Van den
Oever, Spijker, Smit, & De Vries, 2010; Witkiewitz, Lustyk, & Bowen, 2012). People
who acknowledge having an addiction admit it becomes habit forming in that they
constantly need the substance, engage in activities to secure their drug, and develop
withdrawal when the drug is no longer available (Falcon & McClung, 2009; Witkewitz &
Marlatt, 2004).
Loss of control is another hallmark of addiction. Loss of control involves losing
previous desires and acting impulsively and uncontrollably to obtain the drug
(Prendergast, Podus, Finney, Greewell, & Roll, 2006). Addicts’ compulsive behavior
may lead to other problems in their lives. Addicts may not realize how their behavior may
become compulsive.
Researchers have identified what they describe as the bottom-up and top-down
processes involving the development and maintenance of compulsive behaviors (Koob &
Le Moal, 2005; Redish, Jensen, & Johnson, 2008). Sellman (2010) noted that people who
engage in addictive behaviors may have damaged the decision-making part of their brain,
which contributes to the debate on whether or not addicts act compulsively. The debate
centers on the idea that while most people exercise free will to make decisions, the
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primitive region of addicts’ brains puts their drug-seeking behavior into motion;
therefore, they make decisions without thinking (Sellman, 2010). Vohs and Baumeister
(2009) indicated that accepting the idea that people are responsible for their actions has
some social implications for addicts. People who accept the idea that they are responsible
for their actions are less likely to engage in behaviors society deems unacceptable.
Researchers have found that opioid dependency is a chronic disease in which the
addict may participate in the same negative behavioral pattern of using opiates despite the
negative consequences (Elora-Orosa et al., 2010; Hellemans, Dickinson, & Everitt, 2006;
van den Brink & Haasen, 2006). The Diagnostic and Statistical Manual (4th ed.; DSM–
IV) defines opiate dependency as “a maladaptive pattern of opioid use leading to clinical
impairment or distress manifested within a 12-month period” (American Psychiatric
Association, 1994, p. 248).
Opiate dependency involves serious withdrawal symptoms that occur when opiate
addicts are no longer consuming the drug (Hellemans et al., 2006; van den Brink &
Haasen, 2006). To reduce their withdrawal symptoms, opiate addicts may return to their
previous usage level and medicate themselves to reduce their stress level. Larance et al.
(2011) noted that some researchers want to distinguish between the physiological
dependency, which includes going through withdrawal, and the disorder itself. Larance et
al. indicated that there are specific characteristics associated with dependency such as
loss of control, craving, solely focusing on using the drug, and continued use knowing
there could be consequences. Therapists need to identify these characteristics when
diagnosing a person with dependency. Larance et al. further noted that there is some
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argument as to whether addiction should be the primary diagnosis for people who use
drugs or alcohol. Until there is a definition that supports the views of researchers and
treatment providers, there will continue to be some debate regarding the definition and
diagnosis. It remains unclear how the substance abuse profession will deal with
diagnosing dependency.
Definition of Opiates
Opioids give addicts a euphoric feeling, and when that feeling is no longer there
or they experience physical withdrawal symptoms addicts may return to their previous
drug-seeking behavior and continue using the drugs (Bart, 2012; Ling, Mooney, &
Hillhouse, 2011). Opiates commonly used are oxycodone and heroin.
Oxycodone
Oxycodone is a prescription opiate taken orally to relieve moderate to severe pain.
Oxycodone is known to have a high potential for misuse and dependency (Middleton,
Lofwall, Nuzzo, Siegal, & Walsh, 2012). People who misuse oxycodone may have severe
withdrawal symptoms and may take more of the drug without their physician’s
permission (Birnbaum et al., 2011; Miller & Gold, 2007). People who are addicted to
oxycodone may snort the drug to achieve the feeling of euphoria (Middleton et al., 2012).
Oxycodone withdrawal is similar to other opiate drugs. The symptoms, which are
the same as other opiate-based painkillers, include anxiety, insomnia, muscle pain, panic
attacks, and weakness (Beardsley et al., 2004). There is a risk of severe withdrawal
symptoms if oxycodone is abruptly discontinued (“Oxycodone,” 2005). Gradual
withdrawal is recommended. As a result, therapists may need to refer clients who
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acknowledge using oxycodone to detox before these clients can begin residential or
outpatient treatment.
Heroin
Heroin was designed to help addicts deal with their addiction to morphine (Gruber
et al., 2006). Despite its negative effects, heroin use among adults has increased (Gruber
et al., 2006). According to the National Survey on Drug Use and Health, older heroin
users continue to use the drug despite their age (Rosen, Hunsaker, Albert, Cornelius, &
Reynolds, 2011; SAMHSA, 2004). People who use heroin are more likely to become
dependent on it within 2 years of taking the drug as opposed to people who use other
drugs (Mowbray, Perron, Bohnert, Krentzman, & Vaughn, 2010). Roddy, Steinmiller,
and Greenwald (2011) found that the majority of 109 heroin users interviewed engaged in
similar behavioral patterns when it came to their drug use. These addicts admitted using
the same amount of heroin daily, working with the same drug dealer, and participating in
similar rituals during their usage (Roddy et al., 2011). These rituals included using the
same amount of heroin in the same setting as well as where usage took place.
Heroin abuse is a serious worldwide health issue (Cousins et al., 2011;
Degenhardt et al., 2011; Haile, Kosten, & Kosten, 2008; Nordit & Stohler, 2008). One
reason for the abuse is that heroin addicts acknowledge that their addiction is chronic,
which includes periods of relapses, increased tolerance, and unusual behaviors in order to
continue their usage despite some negative consequences (Levran et al., 2009). A number
of problems are associated with heroin use. High mortality levels and serious health
problems are associated with long-term heroin dependence (Ross et al., 2005). Heroin use
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can lead to increased risk of overdose, legal problems, and some health difficulties
(Roddy et al., 2011). Others have indicated that heroin addicts crave the drug or become
involved in illicit activities to secure the drug (Faarred, Vayalapalli, Casarella, Amar, &
Drexler, 2010; Greenwald, 2002; Roddy et al., 2011). Therefore, it appears that the
continued use of heroin causes major problems in users’ lives. As one moves forward
into examining how the United States engages in the treatment of heroin, it may be
important to examine other countries’ policies for treating heroin addiction.
Harm Reduction
Harm reduction is the policies, programs, and practices that aid in reducing the
negative impact of drug use on the addict (Jarvinen, 2008; McKeganey, 2012). Although
total abstinence may be the goal for some programs, others see harm reduction as a
reduction in drug use or using alternatives such as methadone to treat the addiction
(Jarvinen, 2008). Although treatment focusing on being abstinent from drugs and alcohol
use is effective, treatment providers and policymakers are seeing the importance of
developing harm reduction interventions as both valuable and pragmatic (Phillips &
Rosenberg, 2008).
Although some people think harm reduction measures, like needle-exchange
services and methadone treatment, increase illegal drugs, De Preux, Dubois-Arber, and
Zobel (2004) indicated that harm reduction did not increase heroin use in Switzerland.
Other countries have developed different strategies for working with people addicted to
heroin. Nordt and Stohler (2006) noted that while other countries support harm reduction
for heroin treatment, the United States continues to incarcerate people for their drug use
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as policy leaders believe that the United States is fighting a drug war. Only recently in the
latter part of the 20th century did some U.S. policymakers consider engaging in harm
reduction for treating heroin addiction. Jarvinen (2008) examined inconsistent attitudes
between treatment providers and addicts and found that harm reduction is providers’
primary treatment goal.
Definition of Relapse
Relapse is a challenge for addicts, particularly in chronic addiction in which
people are likely to relapse even after being in treatment. Relapse is prevalent in people
experiencing addiction (Sinha, 2011). Treatment providers have indicated that relapse is a
symptom of the problem and can be continuous over the addict’s lifetime (Alemi, Haack,
& Nemes, 2004). Society has often considered the term relapse to indicate a person’s
failure in recovery (Sinha, 2010). However, in view of the previously mentioned studies
relapse should not imply that addicts will remain sober for their life. The studies led to
improving the understanding of how relapse is a challenge for addicts dealing with urges
and cravings associated with stress, depression, and poor support system. In studies by R.
M. Brown and Lawrence (2009) and Sinha (2011), more than two thirds of opiate addicts
relapsed within a few months after completing treatment. Several factors can predict
relapse risk, including stress, depression, craving, coping skills, and a person’s support
system (Sinha, 2010; Witkiewitz & Marlatt, 2004).
Regardless of the amount of time in and type of treatment, relapse is significant
among opiate addicts. As such, it is important for people working in the field of addiction
not to attack addicts who relapse, but to help them pinpoint their triggers and develop a
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relapse prevention plan to overcome them. Understanding why treatment providers see
methadone as the reliable treatment for opiate addiction will give therapists information
to share with clients regarding their treatment choices.
Drugs Used to Manage Opiate Addiction
Methadone
Methadone is a morphine-like drug for treating opiate addiction (King & Best,
2011) that can stabilize opiate users. Methadone is a form of opiate replacement therapy
designed to decrease heroin use and other health problems associated with opiate use
(Dobler-Mikola et al., 2005). Physicians have prescribed methadone for heroin users in
the United States since 1963 (Uchtenhagen, 2011). Methadone is considered one of the
most valuable options in managing heroin and other opiate addiction (Kastelic, Dubajic,
& Strbad, 2008).
Methadone appears to be effective in treating most opiate addiction. Reviewing
data over a 22-year period, Kornor and Waal (2005) noted that heroin addicts who started
methadone treatment but stopped were more likely to relapse and return to the same level
of usage. Methadone may help improve some opiate addicts’ lives. Banta-Green,
Maynard, Koepsell, Wells, and Donovan (2009) completed a 12-month study on
individuals addicted to opiates in the state of Washington. Examining the addicts’
retention in a methadone treatment program, Banta-Green et al. concluded that
methadone treatment significantly improved the lives of people who were diagnosed with
prescription opiate dependency as compared to individuals who only used heroin.
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Despite its proven effectiveness, not everyone who needs methadone can get it.
Schwartz et al. (2008) noted that due to a lack of funding and equality regarding payment
for treatment, some people are unable to secure methadone. Schwartz et al. further noted
that some opiate users may be hesitant or have negative attitudes about quitting their drug
use, which excluded them from a methadone program. As methadone has been the most
recognizable treatment for opiate dependency, therapists should become familiar with its
properties. Termorshuizen et al. (2005) studied 732 participants in Amsterdam and found
that opiate addicts who used methadone maintained their abstinence on a dose of 80 mg a
day or higher. Kayman, Goldstein, Deren, and Rosenblum (2006) identified the
importance of social conditions, program factors, and clients’ characteristics and attitudes
in predicting how long an individual may stay in methadone treatment.
Buprenorphine
Approved in 2002, buprenorphine is an alternative to methadone for treating
opiate dependency (Tetrault & Fiellin, 2012; Wish et al., 2012). Buprenorphine is often
used as addicts are unlikely to abuse it yet has effectiveness similar to methadone (Tkacz,
Severt, Cacciola, & Ruetsch, 2011). Combined with another opiate blocker such as
suboxone, buprenorphine helps reduce opiate abuse (Proctor, Copeland, Kopak,
Herschman, & Polukhina, 2014). Although methadone has been the main
pharmacotherapy used in the United States for treating opiate dependency, buprenorphine
treatment has increased (Gryczynski et al., 2013). Early studies on buprenorphine
indicated that it was a safe alternative to methadone as heroin addicts on buprenorphine
reported using less heroin (Ling & Wesson, 2003). Riksheim, Gossop, and Clausen
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(2014) completed a 10-year study on opioid maintenance treatment. When comparing
methadone and buprenorphine, Riksheim et al. found that buprenorphine use increased
three times during the study period while treatment attrition decreased.
Buprenorphine minimizes any abuse of the drug as well as the addict seeking
other opiates while maintaining all positive qualities of methadone (Tkacz, Severt,
Kassed, & Ruetsch, 2012). Although some addicts acknowledge abusing methadone,
buprenorphine’s abuse levels are lower, and its treatment qualities are similar to
methadone (Tkacz et al., 2011). Buprenorphine has helped reduce early stages of relapse
and was demonstrated safe as compared to another opiate agonist (Wilford & Maxwell,
2006). Buprenorphine is effective in treating opiate addicts, is accepted for treating
addicts, and is another medication-assisted treatment for opiate addiction (Mendelson,
Flower, Pletcher, & Galloway, 2008).
Naloxone
Naloxone is an artificial antagonist used for treating addition to various opiates,
including heroin, morphine, or buprenorphine (Hill & McCauley, 2012). Naloxone is
used to reduce mortality from opiate overdose (Strang et al., 2008) and was designed to
reverse heroin’s effects by reducing respiratory depression, the primary cause of death in
an overdose (Kerr, Dietz, & Kelly, 2008). Naloxone can be effective in treatment and can
reduce methadone dose monitoring (Bell, Shearer, et al., 2009).
Nondrug Treatment for Opiate Addiction
Addiction treatment may range from detoxification to 12 step meetings. Haile et
al. (2008) noted that most individuals who use illicit drugs do not develop an addiction
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and do not need treatment. However, people who do develop an addiction may require
specific treatment. Detoxiﬁcation is a form of treatment for addicts who are physically
dependent on their drug and may need medical and mental health treatment to aid the
recovery process (Sigmon et al., 2012). Some individuals may need a detox program
before they can address their addiction. Miller and Gold’s (2007) study on opiate
prescription medication showed that the perception of pain diminished if the person was
involved in a detox program. Addicts and providers should not view detox as a
standalone treatment as by doing so increases the chance of relapse (Tuten, Jones, Lertch,
& Stitzer, 2007). Although some opiate addicts may need to detox before addressing their
addiction, some may continue presenting with symptoms indicating that they may
struggle without their pain medication. Nonetheless, more than 50% of individuals who
start detox treatment fail to complete it (Marhe, Waters, van de Wetering, & Franken,
2013).
Providers have recognized and accepted the need for residential treatment for
some addicts. Conner, Hampton, Hunter, and Urada (2011) reviewed treatment data from
the California Alcohol Drug Data System from July 1, 2001 to June 30, 2006 and found
higher treatment completion for individuals who were involved in residential treatment
compared to traditional outpatient treatment. Witbrodt et al. (2007) compared addicts
who completed a residential treatment program to those who were only involved in
outpatient treatment. Study results showed that more than 50% of addicts involved in
either treatment modality reported maintaining their abstinence from drugs 1 year after
completing treatment. Although there appears to be different thoughts as it relates to the
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impact residential treatment has on maintaining an addict’s sobriety, no one has
questioned the need for other treatment resources (Witbrodt et al., 2007). Opiate addicts
may need additional resources for completing treatment. Milligan et al. (2011) studied
women’s treatment and found that helping women address their childcare needs and
locate appropriate housing after completing treatment improved the women’s stay in
treatment.
Some individuals may need to go through treatment numerous times to address
their addiction. The Department of Alcohol & Drug Services of Santa Clara County,
California’s report on nearly 1,000 addicts involved in the criminal justice system
indicated that 38% returned to treatment within 18 months of their initial treatment
experience due to a lack of additional programming following their residential stay
(Stanford, Banerjee, & Garner, 2010). In drug addiction treatment, as with other chronic
conditions, addicts are likely to relapse without some type of monitoring.
Although the percentage of people who acknowledge having an addiction to
various opiates has increased, there has been a decrease in the number of addicts
receiving treatment in programs that can address their specific needs (Conner et al.,
2011). People are not always placed in the best program for their addiction needs.
Tetrault and Fiellin (2012) stated opiate addicts need to be in treatment programs that
allow them to use different medications in order to remain sober. Despite the idea that
some addicts will do better in treatment if they are allowed to take medications,
Ducharme et al. (2006) stated that some treatment programs often discourage or prevent
addicts from using methadone maintenance treatment while in the treatment program.
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Thus, the debate continues on whether medication benefits individuals who are using
other treatment modalities.
Problems Associated With Opiate Use
Many opiates, legal and illegal, can be misused. Morphine, oxycodone, and
fentanyl are legal opiates for pain management (Byrne, Lander, & Ferris, 2009). Opium
and heroin are illegal opiates (Wesson & Smith, 2010). Ling et al. (2011) identified
several studies regarding drug abuse in the United States and concluded that prescription
opiates misuse has increased to an epidemic status since 1990. People may be using
methadone and buprenorphine medications for addiction treatment (Degenhardt et al.,
2011; Weiss et al., 2010). Older adults use as much as one third of all prescription
medications, which include opiates and benzodiazepines (Gossip & Moos, 2008). Older
adults may use more medication than their doctor prescribed or use medications
belonging to someone else. In addition, older adults may swap or sell their prescription
medications thus impacting their well-being and support network (Doukas, 2011).
Pain Management
People use prescription opiates for managing pain. Some pain management
organizations support using opiate medications to help people manage their pain (Larance
et al. 2011). Miller and Gold (2007) studied individuals using different opiates for pain
management and noted that less than 1% became addicted to opiates. Pain management
workers who treat older adults need education on how a person may become dependent
on pain medications (Byrne et al., 2009). Therapists may need to develop different
treatment strategies for addressing opiate addicts who take specific opiates for pain
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management and collaborate with medical professionals to provide the best possible
treatment for these clients.
Dangers of Opiate Drugs
There are benefits and problems associated with using opiates. One benefit is that
opiates help manage acute or chronic pain (Larance et al., 2011; Naliboff et al., 2006).
One problem connected with the use of prescription opiates is that people may develop an
addiction to the drug and need more of it. Another problem associated with opiate use is
the impact on society such as violence inflicted on others, property damage, crimes
related to acquiring and selling the drugs, and death (Cruts, Buster, Vicente, Deerenberg,
& Van Laar, 2008; Grau et al., 2007; Panchanadeswaran, El-Bassel, Gilbert, Wu, &
Chang, 2008). Heroin use may lead to overdose. One in 10 heroin users is likely to die
because of an overdose (Degenhardt et al., 2011; Fatovich, Bartu, Davis, Atrie, & Daly
2010).
Drug use is connected to violent behaviors including intimate partner violence
(IPV). Women involved in IPV may develop serious health problems (Chermack et al.,
2009; El-Bassel, Gilbert, Wu, & Hill, 2005; Stuart, O’Farrell, & Temple, 2009). Women
who admit to being addicted to various drugs and also involved in an IPV relationship
related to their drug use reported experiencing anxiety, depression, posttraumatic stress
disorder, and an increase in alcohol and drug use compared to women not involved in an
IPV relationship (Temple, Stuart, & O’Farrell, 2009). According to Panchanadeswaran et
al. (2008) women who are addicted to various drugs and who are involved in an IPV
relationship may also isolate themselves from family and friends, which may make them
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more vulnerable to violence. Drug treatment programs and establishments that provide
services to IPV victims need to collaborate on policies for assisting victims in recovery
and life issues (El-Bassel et al., 2005).
Women involved in substance abuse and who are victims of physical abuse need
to work on reestablishing their social networks. Several studies have indicated that
interpersonal relationships may have conflicting effects for women with addiction
problems as these relationships may be supportive but also may be an impetus for relapse
(Hamilton & Grella, 2009; Walitzer & Dearing, 2006). Stuart et al. (2009) noted the
importance of identifying and treating the violence and addiction in the relationship early
on. Stuart et al. found that abusive partners reported a significant decrease in their violent
behavior a year following their treatment. IPV, psychiatric issues, and high-risk sexual
behaviors are just the tip of the iceberg regarding issues among opiate users.
Previous research has suggested a correlation between addiction and violent
behavior against another person (Lipsky, Caetano, Field, & Larkin, 2006). When
considering both demographic and substance use factors, Lipsky et al. concluded that
people connected to drugs are more likely to use emergency rooms and shelters due to
some type of violent behavior. Older addicts are subject to violence as well. Older addicts
have indicated being the victims of violence and power struggles with drug dealers due to
their age (Anderson & Levy, 2003). Older users noted that having a different background
or social status than their dealers may have caused some of the personal conflicts
(Anderson & Levy).
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Illegal Drug Use
Illegal drug use among older individuals is major concern. Like younger addicts,
older addicts use illegal drugs (Colliver, Compton, Gfroerer, & Condon, 2006; Hamilton
& Grella, 2009; Rosen, 2004; Rosen et al., 2008; Simoni-Wastila & Yang, 2006).
Studying the connection regarding life stressors and exposure to illegal drug use, Rosen
(2004) researched 143 adults over age 50 years and found that their exposure to illegal
drugs greatly increased their involvement with the substance.
Much attention has been paid to the harmful effects of prescription medications.
Cleland, Rosenblum, Fong, and Maxwell (2011) noted that during a 10-year period,
treatment programs reported a 4% increase in prescription opiates being people’s primary
drug of choice. As opiate addicts aged, they have gone from using heroin as their primary
drug to other opiates in order to meet their drug needs (Anderson & Levy, 2003). This
behavior may suggest that even though society does not accept the idea that older drug
addicts use illegal drugs compared to their younger counterparts, older drug users will
find a way to secure their drug needs.
Similar to younger people, older adults may abuse legal and illegal drugs. Older
adults may become addicted to psychoactive medications (Gfroerer et al., 2003). Like
younger addicts, older addicts obtain psychoactive medications without having a written
prescription (Crome, Sidhu, & Crome, 2009). Older adults may also share highly
addictive medications or take higher doses for longer periods than were originally
prescribed (Anstice, Strike, & Brands, 2009; Simoni-Wastila & Yang, 2006). Older
adults’ illegal drug use is expected to rise as the population ages and enters retirement
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(Simoni-Wastila & Young, 2006). Continued exposure to illegal drugs in the older
addicts’ social network and community will likely increase the chances of their
continuing such behavior.
Addiction and HIV
The incidence of alcohol or other drug addiction among HIV-infected individuals
is significantly higher than that of the U.S. population that does not have HIV (Benard et
al., 2007). Users of injected drugs are at high risk of contracting HIV through reusing and
sharing syringes and other injection paraphernalia. In 2006, 24% of persons living with
HIV had been infected through injecting drugs (Meade, McDonald, & Weiss, 2009).
Approximately two thirds of heroin users inject the drug and thus are at high risk for HIV
infection. Compared to nondrug users, female drug users are at a greater risk of HIV due
to their increased sexual behaviors (Cohen et al., 2009; El-Bassel et al., 2005; Kelly et al.,
2009). Burns, Conroy, and Mattick (2010) noted that women who have a substance abuse
problem are more likely to be exposed to health problems due to injecting drugs and
engaging in unprotected sex in exchange for drugs. Significant comorbidity exists
between HIV infection and substance use disorders as they are linked (Byrd, Murray,
Safdieh, & Morgello, 2012). Opiates abuse is a major transmission route while abuse of
other illicit substances, such as cocaine and methamphetamine, has become a primary
risk factor for HIV infection (Centers for Disease Control, 2007).
Sexual Behaviors in Addiction
There is a link between drug use and sexual risk behaviors. Several researchers
have found that people who use illegal drugs are more likely to engage in risky sexual
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behaviors (King, Nguyen, Kosterman, Bailey, & Hawkins, 2012; Kopetz, Reynolds, Hart,
Kruglanski, & Lejuez, 2010). Hayaki, Anderson, and Stein (2006) found that heroin users
engaged in risky sexual activities such as acting without thinking. Cohen et al. (2009)
indicated that a disproportionate number of women involved in substance abuse treatment
acknowledged childhood sexual abuse that contributed to their drug usage. Women are
more susceptible to the negative consequences of drug use and high-risk sexual
behaviors. Programs designed to treat women with drug problems, particularly those who
may be a victim of childhood sexual abuse, may provide a special opportunity to focus on
and treat both issues. Treating both is relevant and beneficial for reducing drug
dependency and improving the lives of these women and their families.
Mortality From Addiction
Mortality is an issue for opiate users. The mortality rate for opioid-dependent
users is 30 times higher than the general population (Clausen, Waal, Thoresen, &
Gossop, 2009). The reasons for their deaths include taking more of the drug than
intended, being the victim of a homicide, committing suicide, or failing to secure
appropriate medical care (Clausen et al., 2008; Clausen et al., 2009). Woody, Kane,
Lewis, and Thompson (2007) found fewer deaths for users who stayed on their
methadone regime. These findings, along with those from previous studies, demonstrate
that staying on methadone reduces mortality as the addict is less likely to return to his or
her using behavior. Figure 2 illustrates the number of deaths contributed to heroin and
prescription opiates over an 11-year period.
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Figure 2. Rates of death associated with heroin and prescription opioids, 2003–2013.
Adapted from “Trends in Opioid Analgesic Abuse and Mortality in the United States” by
R. C. Dart, H. L. Surratt, T. J. Cicero, M. W. Parrino, S. G. Severtson, B. BucherBartelson, & J. L. Green, 2015, The New England Journal of Medicine, 372, p. 241.
Copyright 2015 by The New England Journal of Medicine.
Mortality affects older addicts as they are at least 6 times more likely to die from
their addiction or from other issues when compared to younger addicts (Crome et al.,
2009). Older addicts are likely to die from an overdose or suicide although medical issues
such as cancer and heart problems may also contribute to their death (Hser et al., 2004;
Kwiatkowski & Booth, 2003). Although older people are nearing the end of their life
cycle, Doukas (2011) found limited research focusing on mortality and the reasons for
their death. Older addicts who continue taking methadone may also continue some
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unhealthy behaviors that could increase the probability of death such as smoking, failing
to exercise, and overeating (Fareed et al., 2009).
Psychiatric Problems in Addiction
Some addicts with an identified psychiatric problem may also self-medicate
themselves with drugs and alcohol. The reason for using drugs and alcohol is to relieve
distresses that may or may not be connected to specific psychiatric problem (Gil-Rivas,
Prause, & Grella, 2009). Because of the stigma of mental health diagnosis, some people
may use opiates rather than address their psychiatric problem (Green, Grimes Serrano,
Licari, Budman, & Butler, 2009; Zacny, Gutierrez, Kirulus, & McCracken, 2011). Using
information gathered from the National Epidemiological Survey on Alcohol and Related
Conditions, Martins, Keyes, Storr, Zhu, and Chilcoat (2009) found that people who were
already diagnosed with generalized anxiety disorder were at an increased risk of taking
nonprescription opiates and had a higher risk of developing an opiate dependency.
Therapists need to understand the impact mental health issues have on people
with addiction. Maremmani et al. (2010) identified several studies on the differences
between men and women with psychiatric disorders. Maremmani et al.’s research
indicated that women are more likely to be diagnosed with depression and anxiety while
men are more likely to be diagnosed with schizophrenia and antisocial behaviors. Further,
researchers have found that women who abuse drugs are more likely to be diagnosed with
psychiatric problems than men (Eiroa-Orosa et al., 2010; Green et al., 2009).
Older opiate addicts are likely to identify with having some type of mental health
issue. Rosen (2004) interviewed older methadone users and found that 57% of the
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interviewees acknowledged having at least one mental health disorder. Depression or
generalized anxiety disorder were the primary diagnoses. Rosen’s results appear to be
similar to those of Firoz and Carlson (2004), who found that at least 25% of older
methadone users admitted to having a psychiatric disorder. Comparing older opiate users
to younger ones, both groups acknowledged mental health problems but older users
denied experiencing posttraumatic stress disorder (Wu & Blazer, 2011). Regardless of
any physical conditions, older addicts are less likely to seek treatment for mental health
issues than their younger counterparts as older addicts see depression and other mental
health disorders as part of the aging process. (Braden et al., 2008).
Medical Problems Associated With Opiate Addiction
Prescription opiates are a problem that treatment providers cannot ignore. Weiss
et al. (2010) indicated that most opiate treatment focused on heroin addiction even though
people had increased the prescription opioid use. Weiss et al. further noted that with
increased opiate prescription use, it is important to understand how these individuals may
engage in treatment. Using different sites for opioid addiction treatment, Weiss et al.
viewed how people addicted to different opiate responded to outpatient treatment of
buprenorphine along with therapy. Weiss et al. stated that most people who take
prescription opioids for treating specific chronic pain do not see themselves as addicts
and want to classify themselves in a different subpopulation.
Older opiate users may have some medical issues that their addiction impacts.
Rosenblum et al. (2007) interviewed 140 methadone clients age 50 years and older.
Fifty-four percent acknowledged having arthritis problems, and 41% suffered from
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hypertension (Rosenblum et al., 2007, pp. 495–496). Data from methadone treatment
programs have indicated that older clients present with pulmonary problems and liver and
kidney diseases as well as other serious infections affecting the quality of their lives
(Rosen et al., 2008). Comparing two different opiate maintenance client groups, Lofwall,
Brooner, Bigelow, Kindbom, and Strain (2005) found that older opiate users had more
medical problems and poorer overall health than younger opiate users. Studying more
than 90 clients age 40 years and older involved in methadone, Fareed at al. (2009) found
that more than 70% had hypertension as well as coronary artery issues. Fareed at al.
concluded that continued methadone use correlated with serious medical problems that
put these clients at risk for premature death.
Criminal Behavior Associated With Opiate Addiction
Addiction may increase the possibility of criminal justice system involvement.
Many heroin addicts are incarcerated because of their drug habit and criminal behavior
(McMillan, Lapham, & Lackey, 2008). Of the 2,000,000 people who were incarcerated in
the United States in 2002, 12%–15% admitted to being addicted to heroin and/or other
opiates (M. S. Gordon, Kinlock, Schwartz, & O’Grady, 2008). Studying research from
several countries, Oliver et al. (2010) found that most opiate addicts supported their drug
use by engaging in illegal activities such as dealing drugs. Even though addicts in the
United States may be incarcerated 4 times as often as compared to other industrialized
countries, their decisions to continue using heroin and other opiates following their
incarceration remains a major problem (A. J. Gordon et al., 2011). Incarceration can be
an opportunity for treating people with opiate addiction. Some opiate-dependent addicts
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may receive treatment while incarcerated or when released (Taxman, Cropsey, Young, &
Wexler 2007). Research supports methadone as highly effective in reducing an inmate’s
addiction to heroin or in reducing criminal behavior (A. J. Gordon et al., 2011; Lobmann
& Verthein, 2009; Oliver et al., 2010; Werb et al., 2008).
Cravings for Opiate Drugs
Opiate addicts experience cravings, which are a physical state that may cause
addicts to seek their drug of choice despite the negative consequences (R. M. Brown &
Lawrence, 2009). Cravings can be part of a withdrawal during which the addict may
identify problems such as lack of sleep, mental health issues, and other discomforts
lasting for an extended period of time (Fareed, Vayalapalli, et al., 2010). Heroin addicts
admit that they often crave for a greater amount of the drug (Fareed, Vayalapalli, et al.,
2010; Wang et al., 2011; Weiss et al., 2010). Clinical studies on heroin addicts have
shown that opiate addicts who use methadone report a decrease in their cravings for
heroin (Fareed, Casarella, Amar, Vayalapalli, & Drexler, 2010; Wang et al., 2011). Wang
at al. (2011) studied 14 former heroin addicts who were medication complaint in longterm methadone maintenance programs. Using an event-oriented functional magnetic
resonance imaging task involving heroin- and non-heroin-related cues, Wang et al. found
that although there were no significant craving changes connected to the task, opiate
addicts’ blood oxygen levels significantly increased when shown heroin-related cues.
Study results showed that even though people may be sober from their drug for a
significant period of time, former opiate addicts continue to react to drug-related stimuli
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and that opiate addicts reported having strong cravings and could relapse when exposed
to heroin cues.
There are medications that may help reduce the cravings for heroin. Fareed,
Vayalapalli, et al. (2010) noted results from seven studies showing that methadone could
reduce heroin cravings. Studying brain activity, Fareed, Vayalapalli, et al. found that
heroin craving is connected to different neural circuits in the brain. Using the 10-point
VAS scale, Fareed, Vayalapalli’s study indicated that rapamycin reduced heroin cravings.
In a study on dopamine transporters, Shia et al. (2008) found a reduction in heroin
craving and anxiety in opiate addicts taking methadone maintenance. Barta, Kurth, Stien,
Tennen, and Kiene’s (2009) study of heroin craving, indicated some inconsistency on
whether or not methadone would decrease cravings in opiate addicts. If addicts using
methadone experienced high self-efficacy they were more likely to have low heroin
cravings (Barta et al., 2009). These studies suggest that methadone could decrease or
have no effect on cravings.
Methadone dosage appears to impact heroin cravings. Greenwald (2002)
suggested that heroin cravings increased when methadone dosage decreased. Results
from later studies supported Greenwald’s findings in noting that addicts had better
craving control when receiving 100 mg of methadone or more daily (Donny, Brasser,
Bigelow, Stitzer, & Walsh, 2005; Fareed et al., 2009). It is important to be careful when
interpreting data from these studies: One issue noted in the majority of these studies is
that cravings may be impacted by other illicit drug use rather than changes in methadone
dosing. Cravings may play a significant role in people’s continued heroin use in spite of
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being in a methadone program. Even though methadone is recognized as a safe substitute
for their heroin use, some participants in Fareed et al.’s 2009 study admitted that their
cravings could be a relapse trigger.
Barriers to Treatment for Opiate Addiction
There are some significant barriers to receiving treatment. Many heroin users rely
on public funding to pay for their treatment, which could be a major barrier due to the
limited number of treatment beds available in many communities (Mowbray et al., 2010).
Research on how addicts engage in their drug use and current barriers to treatment is
needed to develop strategies for organizing treatment programs and developing
appropriate interventions for all opiate users.
Several barriers may affect treatment for substance abuse in older individuals.
One is the stigma associated with drug use. Stigma is seen as one of the most extensive
barriers preventing older addicts from seeking treatment (Conner & Rosen, 2008).
Completing a qualitative study at a methadone clinic, Conner and Rosen (2008) found
that older adults identified how society views people with addiction as a negative stigma.
Older female addicts indicated that some family members had discouraged them from
being in treatment as the family members may struggle with the stigma of having a close
relative with a drug problem (Conner & Rosen, 2008; Koenig & Crisp, 2008).
Having a drug problem is one of the most significant stigma older addicts
identify. Older addicts admit feeling angry and embarrassed by society stigmatizing them
as drug addicts (Ayres et al., 2012). This feeling of shame and embarrassment often
keeps older users from being honest about medical problems related to their drug use.
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Koenig and Crisp (2008) noted that these barriers can impact service delivery and
treatment for older addicts. As older individuals age and are identified with an addiction
problem, treatment program providers need to understand how stigma impacts older
opiate addicts and develop treatment strategies that are sensitive and ready to address
these stigmas.
Policymakers may need to revisit existing policies to see if these policies meet the
needs of older addicts. Service providers who accept Medicare are limited in the number
of treatment contacts with Medicare recipients, which makes it difficult to treat clients
consistently (Kaskie, Imhof, & Wyatt, 2008). One problem associated with aging
individuals who present with mental and substance abuse problems is that services do not
correspond very well with the need for their care as less than 25% of older adults needing
treatment will receive individual therapy (Kaskie et al., 2008). Completing a report on the
aging, the Administration on Aging called for the improved integration of services
between the aged person’s primary care physician and his or her treatment provider
(Hinrichsen, 2010).
Older Addicts
Substance abuse affects people regardless of their age. There is some discrepancy
in how older adults are defined. Researchers in the United States have defined an older
adult as anyone 50 years of age and older (Gfroerer et al, 2003; Simoni-Wastila & Yang
(2006). Other countries such as Great Britain have defined an older adult as anyone 40
years of age and older (Crome et al., 2009). As the U.S. population ages, there will be a
major increase in the number of older adults needing addiction treatment (Gfroerer et al.;
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Gossop & Moos, 2008). It is estimated that the number of individuals 50 years of age and
older needing addiction treatment may increase as much as 300% by the year 2020
(Crome et al., 2009; Gossop & Moos; Gfroerer et al.; Rosen, 2004; Simoni-Wastila &
Yang, 2006).
Despite the increased amount of information regarding the epidemiology and/or
treatment for addiction among older adults, there was not research on this subject until
the early part of the 21st century (Kwiatkowski & Booth, 2003). There has been limited
research regarding methadone treatment for opiate addiction in older adults. Doukas
(2011) stated that while methadone maintenance treatment programs have existed for
over 60 years, these facilities are now treating patients who are older and may be
presenting for treatment for the first time in their 50s, 60s, and even their 70s.
Rajaratnam, Sivesind, Todman, Roane, and Seewald’s (2009) study of methadone clients
indicated that older methadone users presented with greater medical needs as well as a
greater need for medications. Unlike their younger counterparts, older drug users are
more likely to use medical treatment and follow up with medical care. With the increase
in older drug users, there needs to be improved communication with health care
professionals. As older addicts are emerging, program providers who serve older people,
particularly drug programs, will need to identify this population’s unique needs (Rosen et
al., 2008). Increased substance use among the baby boomer population will place greater
demands on treatment programs not equipped to address this population’s needs (Lofwall
et al., 2005; Rosen et al., 2008).
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Levy and Anderson (2005) labeled older drug users as having a drug career due
to their long history of drug use. The idea of having a drug career has been used to
explain how addicts begin using their drug of choice and continue as they become
chronic drug users (Kwiatkowski & Booth, 2003). With addicts’ continued use as they
age, addicts are no longer the primary persons involved in the drug culture, and their
involvement in the drug world may be unknown to others unless they become the victims
(Anderson & Levy, 2003). As the drug world older addicts first became involved
disappears, older addicts may lose their social status as and try to hold on to past selfidentity and cultural values.
Summary
Opiate addiction is a complicated issue. People who continue their opiate use
despite such consequences as death and incarceration recognize that many factors can
possibly affect their usage. Feelings of powerlessness and unmanageability are so great
that people addicted to opiates understand that their lives have become unstable.
There is limited information supporting any significant gender differences for
older opiate addicts. There are considerable similarities related to the interactive effects
of substance use and aging and social relationships. Such gender problems may continue
and even intensify as these addicts age. As women age, they may face different barriers
and facilitators to gaining access to treatment as opposed to younger women. Younger
women often see their parental roles impeding their decision to seek treatment while
older women identify issues such as mobility and age-related health problems affecting
their ability to engage in treatment. As addicted women age and become more involved
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with the health care system, additional research is needed on possible gender differences
in the course of their addiction and treatment. Even though substance misuse is increasing
and is becoming a significant problem for older adults, there is little information about
older adults who may misuse substances. Professionals who work with this population
may lack practical skills needed for addressing some difficult ethical issues that may
come about in the context of working with older opiate addicts.
Further discussion regarding the techniques used to gather information for the
literature review as well as the techniques used to gather information regarding
methadone usage, relapse issues, and live experiences is in Chapter 3. Chapter 3 includes
a discussion of ethical considerations, study methodology, the sampling method, and the
recruiting process.
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Chapter 3: Research Method
Understanding a phenomenon requires in-depth knowledge of the perspectives of
those who have lived through the experience. Qualitative research serves as a conduit for
this process in an organized and systematic fashion (Marshall & Rossman, 2006). Tesch
(1990) stated that individuals assign meaning to their objective world and that their
valued experiences are situated in a historical and social context. Tesch further stated that
there can be multiple realities for these experiences.
My intent for the present study was to use a heuristic phenomenological approach
to explore the lived experiences of opiate users ages 50–55 years currently on methadone.
I examined their lives, their addiction history, and how using methadone has influenced
their lives. Treatment providers may need to review this population’s physical and mental
health as well as continued drug use. I gathered data related to participants’ history of
use, any relapses, and length of time on methadone. I also wanted to know about any
relapses as well as other treatment modalities participants used while taking methadone.
Interviewing these individuals provided information regarding how they perceived their
lived experiences, addiction, and treatment experiences.
Examining Lived Experiences
Van Manen (1990) stated that when studying a phenomenon, a qualitative method
is the most relevant tool to use as the study will be exploratory in nature. The goal of
qualitative research is to provide information to gain a better understanding of an
occurrence (Braud & Anderson, 1998; Creswell, 2007; Denzin & Lincoln, 1998;
Moustakas, 1994). I selected a qualitative study because my focus was on conducting a
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thorough investigation of the lived experiences of older methadone users. Patton (2002)
described a lived experience as researchers having direct involvement with the
phenomenon of interest instead of gaining the information from secondhand sources.
Denzin and Lincoln (1998) indicated that a qualitative method is the best scheme for
studying human experiences in order to gather the phenomenon’s complexity.
Phenomenology
Phenomenology is the study of lived experiences or the life world (van Manen,
1990). Husserl designed the phenomenological research method in the early part of the
20th century as a response to the traditional scientific method (Giorgi & Giorgi, 2001;
Laverty, 2003; Lin, Huang, Chen, & Shao, 2009). Husserl argued that the traditional
scientific method could not adequately or appropriately capture a phenomenon’s
abstractions due to its focus on measuring observable concrete events (Powers & Knapp,
1995). Phenomenology is the chosen methodology when wanting to understand the
essence of an experience (Creswell, 2007). Phenomenological research invites the
researcher to observe the participants’ world and learn different human behaviors (Valle
& Mohs, 1998).
In review, the focus of a phenomenological study is on exploring the relationship
between people and their lived experiences, taking into consideration their customs,
community, and historical environments. Combined, these factors may impact the ways
in which people observe, identify with, and make sense of their daily experiences
(Heidegger, 1962). Therefore, a hermeneutic phenomenological study of older opiate
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users coincides with an informative concept for examining participants’ lived experiences
on methadone.
Taking a phenomenological approach allowed me to explore participants’ lived
experiences from a first-person point of view (Smith, Flowers, & Larkin, 2009; van
Manen, 1990). Basically, phenomenology allowed me to examine participants’ life
worlds as they were deliberately and purposely reflected upon (Husserl, 1998). Taking a
phenomenological approach allowed me to explore the significance, for some people, of
their lived experiences in relationship to a particular phenomenon (Polkinghorne, 1989).
The present study focused on the lived experiences of opiate users ages 50–55 years
currently on methadone. I examined their lives, their history of addiction, and how
methadone use has influenced their lives.
Braud and Anderson (1998) indicated that phenomenology is used to create a
clear explanation and awareness of a specific human experience. To acquire a good
understanding of the lived experiences using the phenomenological approach, researchers
need to study fewer participants but do so more meticulously (Creswell, 2009;
Moustakas, 1994). In the present study two different heuristic techniques were used to
study older methadone users.
The Heuristic Approach
Heuristic research characterizes the phenomenological emphasis on meaning
through personal experiences. The two methodological techniques used for heuristic
inquiry in the present study were engaging in a face-to-face conversation with the
participants and personalizing the phenomenon. The phenomenon is personalized by
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having the participants’ experiences as the focal point throughout the research
(Moustakas, 1990; Patton, 2002). For the present study, I engaged in conservation as part
of the heuristic approach. I spoke, listened, reflected, and talked again to the participants
to gain a clearer understanding of the phenomenon. Moustakas (1990) suggested that this
method involves cooperating and sharing to open a pathway for explicating the
phenomenon being investigated.
There are four approaches to phenomenology research: traditional, experimental,
hermeneutical, and empirical or transcendental (Klein & Westcott, 1994). For the present
study, the hermeneutical approach to phenomenology using the work developed by van
Manen (1990) was chosen as a suitable methodology. Hermeneutic phenomenology has
become a more popular research method as it is used to examine life world or human
experiences as the study has a focus on revealing the specific and seemingly trivial
aspects in the experience that others may take for granted (Laverty, 2003; Wilson &
Hutchinson, 1991). Hermeneutic phenomenology also involves a presupposition that the
essence of an experience is interpretable, and therefore knowable.
Hermeneutic phenomenology is attentive to the philosophical foundation of
hermeneutics and phenomenology (van Manen, 1990). Ajjawi and Higgs (2007) noted
that to be successful, research strategies need to flow directly from the project’s research
question and goals. This methodology aligned with my goal of attempting to understand
the lived experience of methadone users ages 50–55 years. In essence, phenomenology
best fit my desire to explore the lives of older methadone addicts. Few studies have been
published on the lived experiences of older methadone users. I chose specific procedures
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consistent with the philosophy of phenomenology to give richness, depth, and insight into
the phenomenon under investigation.
Research Questions
I focused on understanding the lives of individuals who were addicted to opiates
who were using methadone as a tool for relapse prevention. I also looked at other
treatment modalities participants were using or had used to remain sober. I formulated
two questions to gain this understanding. The first question was what are the lived
experiences of opiate users ages 50–55 years who take methadone to manage their
addiction? A subquestion was how do opiate users ages 50–55 years on methadone
remain consistent in their methadone treatment so that they can stay in recovery? The
second question was how do opiate users ages 50–55 years relate their particular
experiences to the idea of recovery? Although the literature review showed that many
researchers have studied methadone treatment as well as addiction and its impact on
society and families, there remain gaps in the research when it comes to methadone use
and older adults. It is possible that continued dependency on a substance, despite it being
legal, is construed differently than maintaining total abstinence from any substance.
Informed Consent Process
To gain access to participants, I obtained the approval from Walden University’s
IRB (Walden University’s approval number for this study: 09-18-15-0133502) to make
sure the interview questions posed no harm to the participants and were asked in such a
way that information flows smoothly and willingly during the interview process
(Charmaz, 2006). During the IRB process, I also addressed my recruitment procedures
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and data collection steps to make sure they were within the ethical guidelines established
by Walden University. Once I received permission, I sent fliers to various places that
addicts are known to frequent. To maintain an ethical study, individuals who agreed to
participate signed a consent form prior to study participation. Participants were invited to
contact me prior to signing the consent form with any questions or concerns they may
have, and I responded appropriately and promptly. Participants could withdraw from the
study at any time without prejudice.
Participants
I sought male and female participants who had been on methadone for at least 2
years, who were involved in a methadone clinic, who were not currently involved in a
residential treatment program, and who resided in one of three metropolitan areas in the
state of Michigan. I identified individuals from a purposive sample based on their ability
to comprehend the research problem and the primary phenomenon being examined in the
study (Creswell, 2007). According to Dukes (1984), eight to 10 participants are an
adequate sample size for a phenomenological study. For the present study, I interviewed
participants until I reached a saturation of methadone users who were 50–55 years of age.
One of the reasons for choosing this particular population is that previous research has
shown that inequalities in being admitted to appropriate treatment programs for substance
use correlate with a greater risk of substance-related death for older adults using
methadone (Clausen et al., 2009).
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Sampling Method
I used a purposive sampling to recruit prospective participants. Purposive
sampling was appropriate as I sought an in-depth understanding of lived experiences
from the participant’s standpoint (Babbie, 2010). Sample sizes for these types of studies
are typically small (i.e., five and 10 participants) to allow for an in-depth, incisive
examination of a phenomenon of interest. Also, purposive sampling is preferred when the
goal is to draw from hidden or marginal populations that are difficult to access (Creswell,
2007). Unlike quantitative studies in which the goal is to generalize to larger populations,
phenomenological research’s aim is to acquire a deep, contextual understanding of lived
experiences (Denzin & Lincoln, 2011).
According to Creswell (2007), purposive sampling refers to selecting people and
the place for the study because both can purposefully inform an understanding of what
the researcher is attempting to learn. Using a purposive sampling allowed me to study a
small subsection of a larger population (Babbie, 2010). It was my hope that by including
only participants who meet the predetermined criteria, these individuals would be
credible informants about the phenomenon under investigation. I chose participants who
met the following criteria: male or female, 50 -55 years old, diagnosed with opiate
dependency, involved in a methadone maintenance treatment program for at least 2 years,
and no relapse reported in the previouss year. This information was gathered from the
background questionnaire that potential participants completed after providing their
signed consent form.
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Participant Recruitment
To recruit participants for the study, I send out fliers to specific places near
methadone clinics in three counties in the state of Michigan to identify potential
participants. I sent fliers to places such as soup kitchens, recreational facilities, homeless
shelters, and churches near the clinics. I also placed fliers in NA/AA meeting places in
the three counties. I contacted therapists who work with people with addictions and asked
them to place fliers in their waiting rooms for possible participants to view and consider.
One agency placed a copy of the flier on its Facebook page, and I put a copy on my
LinkedIn page. Appendix A is a sample of the recruiting flier.
I used insiders to gain access to potential participants. Creswell (2007) identified
insiders as individuals used to gain access to a group or cultural site. Insiders for the
present study were leaders of NA/AA groups and therapists. Because of the close-knit
culture of addiction and possible mistrust of researchers, insiders were vital to the present
study as they helped ease any preexisting tension between the field of social science and
the addiction community. This relationship gave me access I may not have been able to
gain on my own. These insiders were individuals with whom I have trusted relationships
and who either were working with the subjects in their clinics or had access to the
subjects via contracts. To ensure no perceived coercion, the insiders’ role was to
advertise in their clinic or meeting place for possible study subjects. The insiders did not
know who participated in the study and who did not. The selection process continued
with selection based on criterion sampling until the N of eight was reached. Once I had
eight participants who met the criteria for the study, I interviewed them.
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Of all of the recruiting modalities, placing fliers in treatment programs provided
the most responses for potential participants. In response to the fliers, I received 12 phone
calls from people in the greater Grand Rapids, Michigan, area who indicated they were
interested in being in the study. I kept a log of all phone calls to keep track of who called
and determined how to send information to them. Although 12 people agreed to
participate in the study, only eight people, four men and four women, completed the
study. As all participants came from the greater Grand Rapids area, there might have
been concerns regarding previous relationships with me. To ensure that there would be no
issues in this area, I eliminated any potential participants who were former clients of
mine. Even though it was a purposive sampling and recruitment fliers were also sent to
large African American and Latino communities in Detroit and Muskegon, Michigan,
none contacted me to participate in the study. As Rencher and Wolf (2013) indicated,
African Americans are often reluctant to participate in research studies due to the feelings
of mistrust about the researchers and how the researchers will treat them.
Once interested individuals agreed to be in the study and appeared to meet the
criteria, I scheduled an appointment for an initial interview. All of the participants
indicated that they did not have an email address to send information before the meeting.
To confirm the interview appointments, I called each participant before the scheduled
interview date.
Individuals who expressed an interest in participating in the study completed the
consent form, which I reviewed with them. I delivered the consent form and
questionnaire in person. The participants were asked to sign the consent form prior to
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completing the background questionnaire. The signed consent form was collected at the
time of the initial interview.

To show my appreciation, each study participant received a

$20 Walmart gift card.
Research Procedure
Data Collection: Individual Interviews
I conducted an in-depth interview with each participant. This in-depth interview
consisted of open-ended questions. By using open-ended questions, I could consider the
views, attitudes, and experiences related to older methadone addicts. I recorded all
interviews for accuracy and clarification.
Transcripts from the interviews were analyzed for any significant statements
using NVIVO 11 software, and significant statements were grouped into larger units or
themes. These themes were then analyzed. I asked the subjects if they would be willing to
have a follow-up meeting in the event I needed clarification as the data emerged. This
follow-up was an option and did not limit people from being in the study. The follow-up
interviews helped me explore themes that developed from the information each
participant shared during the initial interview phase.
Initial Data Collection: Background Questionnaires and In-Depth Interviewing
Each participant signed an informed consent and was instructed to complete a
background questionnaire. The background questionnaire served as a means to illicit
descriptive data about each participant and to ensure that each participant was best suited
to help me examine and explain phenomenon in question. After the background
questionnaire was completed, each participant was invited to take part in a face-to-face
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interview. Participants were notified on the consent form that the interview would be face
to face.
I spent 60 to 90 min conducting a semi-structured interview with each participant.
The interview consisted of open-ended questions related to the research topic that
allowed the participants to respond in their own words. Using specific questions and
probes helped me explore the participants’ responses and descriptions of experiences
related to the research questions. I recorded all interviews with a digital recorder and
saved the recording on a flash drive. I also took notes to document any of my perceptions
and biases related to older methadone users.
Questions for the participants were the following:
•

What does it mean to be an older person who takes methadone?

•

What types of opiates were you addicted to?

•

How long have you been on methadone?

•

Besides methadone, what other treatment are you using to stay sober?

•

Can you describe any past or present issues that helped you continue your
recovery from your opiate addiction?

•

Describe the circumstances that led you to decide to discontinue your drug use
and use methadone.

•

What types of barriers prevent you from accomplishing treatment goals
established by you and your case manager?

•

How did your addiction impact your relationships with others?

•

What are your family and friends’ perceptions of methadone users?
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•

What factors do you contribute to shaping these perceptions?

•

How do your family and friends interfere with your treatment program?

•

Do you feel that race, gender, or social status play a role in the services you
receive for your opiate addiction?

•

Can you identify any health issues that are preventing you from being involved in
your treatment program?

•

How could treatment providers best serve you therapeutically if you were to seek
additional services?

•

Are there any other aspects, being your age on methadone, such as views and
attitudes on help-seeking that have not been explored that you would like to add?
Interview Procedures
All participants selected interview sites that were convenient for them to travel to

with few issues. I conducted the interviews in places near the participant’s home. Half of
the participants used public transportation or walked to the interview site. Before
interviewing, each participant read and signed the consent form (see Appendix B) and
then completed the demographics form (see Appendix C).
I gave each participant ample time to read the consent form and ask any
questions. I also reminded all participants that their participation was voluntary and that I
would treat any information they disclosed as confidential. I asked all participants if they
wanted a copy of the consent form, but all refused. I kept the completed demographic
questionnaire and consent form for my records. During the initial interview, I asked
participants questions crafted to evoke detailed accounts of issues related to their
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addiction and methadone use. To show my appreciation, I gave each participant a $20
Walmart gift card.
Initial interviews ranged between 60 to 90 min. As stated on the consent form, I
audio recorded each interview. I secured all information, audiotapes, and written notes in
a locked cabinet located in my office. As stated on the consent form all information will
be kept in a secured file cabinet for 5 years after study completion. Except for the consent
form, I did not provide any other identifying information on any other form, and I gave
each participant a pseudonym that only I knew. I also kept this information in a locked
cabinet located in my office.
In a phenomenological study, the researcher typically uses a long interview to
collect data on the topic and questions (Moustakas, 1990). As I asked open-ended
questions, which varied depending on the participant’s responses, time was not the sole
factor affecting research completion. However, I valued the time of anyone who agreed
to be part of the study. Therefore, I limited the interview to 1.5 hr, and I met the
participants at an establishment of their choice.
Researcher’s Role
My role as the researcher was to direct the research study toward its established
goals (Creswell, 2007). For the present study, I strived to gather information about opiate
addiction and methadone use. I interviewed eight people ages 50–55 years and using
methadone to treat their opiate addiction. It was important that I assured the questions I
asked were appropriate and that the questions reflected the information needed from
participants (Creswell, 2007). It was also important that I avoided showing bias as much
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as possible. Therefore, I informed all participants of my work as an addiction therapist. I
further allowed them an opportunity to ask me questions regarding my attitude about
addiction and older addicts. During the data analysis process, I needed to use the data
very analytically and as appropriately as possible in order to derive themes from the
phenomenon of opiate addiction and methadone use (Lien, Pauleen, Kuo, & Wang, 2014;
Patton, 2002).
My main responsibility was to ensure that the participants understood the
questions asked of them, felt comfortable talking about their addiction and that they
finished discussing their answers to the questions at their own pace in order to bring
about the best possible and most usable answers. Although I may have some perspectives
regarding methadone use, it was also important for me to realize that the participants had
important information that must be explained and analyzed in order to accurately
interpret the results. In addition to recording the information, I took notes and listed such
issues as facial expressions, body language, and other nonverbal expressions that helped
me interpret the data.
Transcript Preparation
I used a transcriptionist who has had confidentiality training to transcribe the
interviews and to ensure participant confidentiality. The transcriptionist was identified in
my application to Walden University’s Institutional Review Board. The transcriptionist
signed a confidentiality statement, agreed to keep all interview data confidential, and
agreed to delete and/or destroy all electronic or paper copies of the transcribed
interviews. The transcriptionist did not live in the area, which further ensured
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confidentiality as the transcriptionist did not know any of the participants. In addition, I
ensured accuracy by using the digital recordings to review each transcription. This also
provided another means of data immersion.
Recorded information from the present study was limited to only those who
needed it; that is, the transcriptionist, my dissertation committee, and myself. The signed
consent form notified participants that their information will be held in confidence. All
information was kept at my office in a locked file cabinet. Participants’ real names were
only kept while the data were being collected and were separated from any of the data
collected. In keeping with Walden University regulations, I kept copies of the participant
list separate from transcribed data in my office in a locked file cabinet. The audio
recordings were erased from the flash drive after the transcripts were completed and
checked for accuracy, pauses, or emphasis.
Data Analysis
I used a modified form of the Stevick-Colaizzi-Keen method (Moustakas, 1994)
for data analysis. This method consists of the following six steps:
1. I began with a full description of the personal experiences of the participants
concerning the phenomenon.
2.

I developed a list of any significant statements.

3.

I grouped the significant statements into meaning units or themes.

4.

I wrote a textural description.

5.

I wrote a structural description.
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6.

I wrote a composite description of the phenomenon incorporating both the
textural and structural descriptions (Creswell, 2007).

In addition, my committee chair and methodologist reviewed the material with me to
assure the accuracy of my assessment and theme building.
Themes
Themes were generated from identifying significant statements in the interview
transcripts or other forms of data. These significant statements dealt with how individuals
experienced the phenomenon being studied. After this process was completed, the
significant statements were gathered in larger units of information known as themes
(Creswell, 2007). For the present study, themes were established through identifying each
participant’s significant statements. I used NVivo 11, a qualitative data analysis program,
to verify groupings of codes and to put them into nodes. I organized each theme area into
one of three domains: views, attitudes, or barriers. These areas were used as salient
themes for the study if at least five of the participants have experienced relating to the
identified theme area.
I connected any relevant portions of text to nodes in the NVivo program. As this
process was evolving, I deliberated on the meaning of each significant text and made
decisions as the text related to the study’s essential themes. NVivo 11 allowed me to
review all of the text and organize the document into a final thematic analysis. The
summary of the information gave me a detailed account of supporting text for each item,
after which I crafted each participant’s phenomenological narrative.
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Bracketing
Bracketing, also known as epoche, is the process where the inquirer removes his
or her experiences, as much as possible, in order to take a nonbiased look at the
phenomenon in question (Moustakas, 1994). This is a major step in conducting empirical
phenomenological research. The goal of bracketing was for me to set aside my
experiences so that I could be as neutral as possible. Several researchers described
phenomenological reduction or what Husserl defined as bracketing (Jones, 1975; Klein &
Westcott, 1994; Polkinghorne, 1983). Husserl saw bracketing as identifying any personal
biases while observing the outer world so that contact with participants can be
successfully achieved. I delayed my decisions or particular ideas regarding the
phenomenon in order to have a clearer understanding of it. Jones (1975) encouraged
researchers to expand their understanding of bracketing beyond postponing their beliefs
about the phenomenon in order to create some skepticism to help expose themselves to
the study. Though Husserl acknowledged the unusualness of this position, he continued
to support it as a viable pursuit (Edie, 1987).
Moustakas (1994) stated that postponing one’s belief is never truly reached. One
way in which I demonstrated the bracketing process was by including a description of my
own experience with the phenomenon and bracketing out my view prior to moving
forward with the lived experiences of others, as suggested by Creswell (2007). I informed
all participants of my work as a substance abuse therapist and acknowledged any
negative encounters I may have had with methadone users.
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Establishing Credibility of Qualitative Data
Immersion
In phenomenology research studies, the immersion process is in place from the
onset of the research through the completion of the study. Immersion began when I used
my experiences to develop opinions about the phenomenon being studied. The immersion
continued by my reading related literature to explore the topic and gain a deeper
understanding as a whole. For example, my experiences with older methadone users who
are dealing with legal issues, family problems, relapse, and cravings who feel they are
unable to access treatment due to stigmas about opiate use prompted me to look for
previous research on treatments for opiate users. I asked participants about their views,
opinions, and any barriers they faced accessing treatment. Exploring treatment issues that
older methadone users face helped me develop interview questions that were situated in
the context of the literature and that spoke to the daily lived experiences of this
population. It was my hope that the participants’ voices were not lost and that their voices
help shape the direction and content of the services that older opiate addicts need.
Member Checks
Member checks require presenting the findings and/or interpretations of the
findings through descriptive triangulation, which creates consistency between the
participants and myself (Leech & Onwuegbuzie, 2007). Member checks are considered
one of the most critical techniques for establishing credibility in qualitative research
designs (Lincoln & Guba, 1985). Member checks was instituted in the present study by
letting the participants know they had the opportunity to read the completed transcripts
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from the initial interview. This gave participants an opportunity to comment or correct
any information that had been gathered. Although member checks are strongly
recommended to ensure data trustworthiness, Carlson (2010) advised beginning
researchers to be cautious prior to carrying out this procedure. Carlson further
encouraged placing any relationship between the researcher and participants up front to
ensure the validation process. Carlson also warned that giving participants large amounts
of information could be overwhelming, especially if any participants have difficulty
comprehending the information.
Research Auditor
The research auditor serves as a mechanism for analyzing the study. The auditor
assists in “keeping the inquiries honest” (Lincoln & Guba, 1985, p. 243). The auditor
may also serve as a source of new ideas or perspectives that will help the researcher see
the bigger picture at hand (Lincoln & Guba, 1985). For the present study, the research
auditor, a member of my dissertation committee, reviewed the initial interview transcripts
for each study participant. The research auditor also used the data to identify the salient
themes that were consistent across the participants. This helped determine if the themes I
identified were evident to an outside researcher. The auditor was also trained in
confidentiality protocol and signed a confidentiality statement agreeing to keep the
content of all of the interview data confidential and to delete or destroy all electronic or
paper copies of the transcribed interviews.
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Transferability
According to Merriam (1998), transferability or external validity concerns the
extent to which study findings can be applied to other situations in a different time or at a
different place. Merriam further noted that transferability indicated that the research will
be applicable or that similar findings for similar participants could be found.
Transferability is also a direct function of the similarity between two contexts known as
fittingness. This idea can be defined as the level of congruence between sending and
receiving contexts (Lincoln & Guba, 1985, p. 124). To demonstrate how this
phenomenon was practical in application to the present study and in other settings,
discussions were provided on how the study was situated in literature, who the
participants were, the chosen methodology, and data analysis.
Triangulation
Triangulation improves the study’s legitimacy by evaluating the honesty of the
interpretations that the researcher draws from more than one vantage point (Lincoln &
Guba, 1985). According to Denzin (1989), triangulation involves using additional data
sources, researchers, different theoretical perspectives, or several methods combined.
With regard to triangulation, I sought data from multiple sources, methadone users from
three different locations through multiple methods (semistructured initial and follow-up
interviews and field data). This provided a more detailed and balanced explanation of
lived experiences of older methadone users. Furthermore, immersion in related literature
helped me examine and interpret the data. For example, contrasting emergent themes and
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patterns with existing literature helped me make meaning of what is similar and different,
and why, thereby increasing my understanding of the investigated phenomena.
Validity
Validity describes a measure that accurately reflects the idea it is intended to
measure (Babbie, 2010). Validity is also defined as “the best available approximation to
the truth of a given proposition, inference, or conclusion” (Trochim & Donnelly, 2008, p.
20). Qualitative validity involves the researcher checking for findings accuracy by using
certain procedures that accept the reliability of the research by testing it against previous
research (Creswell, 2009). To verify that the findings in the present study represented the
experiences of older opiate users, I agreed to share the research findings with study
participants. I also agreed to make revisions if any participants indicated that I failed to
identify their perceptions of their lived experiences as older methadone users.
Trustworthiness involves ensuring that study outcomes are credible or acceptable to the
people involved in the study (Trochim & Donnelly, 2008). As the present study’s purpose
was to explain or recognize the phenomenon from the participants’ point of view,
participants were the only ones who could determine the study’s trustworthiness and
credibility.
One threat to validity is research bias, where the researcher may place his or her
expectations into a study (Isaac & Michael, 1997; Maxwell, 1996). The concern is that
the researcher’s bias and expectations may invalidate the study results. One bias in the
present study was a concern that I do not have a history of opiate dependence and
methadone use. Another bias I had to acknowledge was that I grew up in an addictive
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family; as such, I have firsthand experience of what addiction does to family members.
Therefore, I may have made assumptions as to whether or not addicts may have healthy
and appropriate lives without relapsing to their drug of choice.
Summary
To summarize, in Chapter 3 I provided an overview of the research methodology
employed in the present study. My discussion included hermeneutic phenomenology, the
specific approach taken, and the qualitative paradigm employed. I also discussed study
participants and the methods that were used to recruit the participants. My role and
worldview were also discussed. In Chapter 4, Iwill discuss results from the information
gathered.
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Chapter 4: Results
The purpose of this research study was to provide a description of the experience
of older methadone users. The research objectives were fourfold: (a) to acquire an indepth understanding of the phenomenon of older methadone users, (b) to elucidate and
describe participants’ experiences of addiction and treatment using their own voices and
perspectives, (c) to extract and develop themes from the data, and (d) to interpret
participants’ lived experiences and meaning constructions in an addiction-related
theoretical framework.
In Chapter 4, I presented the findings of the lived experiences of older methadone
users and their views, attitudes, and barriers regarding using methadone for their
addiction. As will be seen in their discussions of their experiences, participants talked
about their thoughts on needing methadone, having relationships with others due to their
addiction, attitudes about using methadone and their opiate addiction, and stigma as it
related to being an older opiate addict needing methadone. The collective core of the
participants’ experiences concerning help-seeking was examined to uncover common
themes in the participants’ individual narratives. By analyzing each participant’s
narrative through a phenomenological analysis structure, I established certain themes.
Chapter 4 begins with an overview of participant demographics and biographical
sketches of each participant. This is followed by a discussion of my findings, including
the identification of five qualitative themes that emerged from the data analysis process. I
recorded all interviews with a digital recorder and had all of the information erased once
it was transcribed.
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Participant Profiles
This section includes descriptions of study participants. All demographic and
biographical data are presented and discussed as being current at the time of the study.
All participants were involved in a methadone clinic and were using methadone on a
daily basis. All but one relied on public funding to pay for their methadone, and most
were not involved in other treatment programs to help in their recovery. Two participants
knew each other, and I omitted all personal information that could make them identifiable
in the following descriptions. Participants were assigned pseudonyms to protect their
identities. Table 1 shows participants’ demographic information.
Table 1
Participant Demographics
Participant

Age

Marital status

Race

Gender

Education

Nancy

50

Single

White/NA

Female

Some high school

William

54

Single

White

Male

Some college

Elizabeth

53

Divorced

White

Female

High school graduate

Danny

55

Single

White

Male

High school graduate

Anna

55

Single

White

Female

College degree

Bernice

50

Single

White

Female

High school graduate

Rex

53

Married

White

Male

High school graduate

James

55

Single

White

Male

High school graduate

Table 2 shows data related to the participants’ time involved in the methadone clinic, the
amount of methadone taken, and whether or not they had other addiction treatment.
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Table 2
Participants’ Treatment History
Years in
recovery

Years on
methadone

Daily amount
of methadone

Other
treatment for
addiction

Nancy

7

7

135 mg

Yes

William

2

2

120 mg

No

Elizabeth

2

2

90 mg

Yes

Danny

4

2

125 mg

Yes

Anna

5

5

145 mg

No

Bernice

6

6

85 mg

No

Rex

8

8

133 mg

No

22

20

165 mg

Yes

Participant

James
Nancy

Nancy is a 50-year-old single biracial female who reported being involved in
methadone treatment for the past 7 years. She stated she lives alone in a subsidized
housing unit and receives Supplemental Security Income (SSI). She reported using a
variety of opiates, including heroin, and has been an intravenous (IV) drug user. Her
involvement with drugs began with a former boyfriend. She stated that her low selfesteem prevented her from saying no when her former partner encouraged her to use
drugs. Nancy reported that to help her eliminate her addiction to opiates in the past, she
was involved in residential treatment three times and used Suboxone for 1 year. She
reported she stopped taking Suboxone due to its cost and not getting the public funders to
continue paying for it.
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Nancy stated that her reason for using methadone was that she was “sick and tired
of being sick and tired.” She acknowledged that she engaged in many different activities
to support her drug habit and had to deal with both shame and guilt. She expressed how
she felt that being a female impacted the services she received and stated that the nurses
do not believe that women are clean if they wear makeup. She voiced a commitment to
staying sober and not returning to opiates in the future.
William
William is a 54-year-old White male who said he had been involved with
methadone for the past 2 years. He stated that he lives alone in an apartment and is
employed full time. He reported using Vicodin 10 mg, pills and Percocet 10 mg pills as
both were easy to obtain on the street as well as snorting heroin. He acknowledged using
these drugs until he became high. According to William, his history of using opiates
began in his mid-30s when he started associating with friends who were using opiates.
William stated that his primary reason for using methadone for his opiate
addiction was that he was “sick and tired of being sick and tired,” but mostly tired of
chasing the drug and then getting caught. He also reported that he engaged in some illegal
activities to support his drug habit but did not want to talk about that part of his life.
Although he did not see his race or gender impacting his methadone treatment, he
reported feeling that some of the staff treated some of his minority associates differently
than him and some of his White associates. William stated that importance of being
involved in treatment was to let everyone know that addiction is a disease and that it
affects all major parts of the addict’s life.
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Elizabeth
Elizabeth is a 53-year-old single White female who stated she had been involved
with methadone for the past 2 years. She stated she lives alone and is employed part time
to help supplement her SSI. She reported using morphine and Fentanyl for her cancer
treatment and later began misusing her medications. Before using methadone, she said
she was involved in outpatient and residential treatment. She also acknowledged trying
Suboxone but said she stopped because it did not relieve her cravings for opiates.
Elizabeth stated that her reason for using methadone was that she needed it to
remain sober while trying to treat her cancer. She indicated that due to her addiction she
became involved in the criminal justice system and spent 3 years in prison. She
acknowledged that she spent money earmarked for household expenses to support her
drug habit. She also reported that because of her addiction, and her history of being an
enabler, she is unable to have healthy relationships or be emotionally close to other
people. Elizabeth expressed concern that treatment providers do not do enough to
eliminate or change the stigma of being on methadone and that there needs to be more
education about the need for methadone clinics due to seeing too many of her friends
dying from their drug use.
Danny
Danny is a 55-year-old single White male who had been involved with methadone
for 4 years. He reported he lives by himself in an apartment and works to support himself.
He reported using a variety of opiates such as Tylenol 3 and 4, Vicodin 10 mg pills, and
OxyContin 80 mg pills all of which he obtained on the streets. He also stated that he
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began using heroin after he developed a high tolerance to these opiates and that he has
been an intravenous drug user. Danny reported that he was previously involved in
residential, intensive outpatient, and traditional outpatient treatment programs to address
his addiction. He stated that he started using opiates after he became involved in the
criminal justice system. He also admitted that he had to deal with some depression and
felt that his drug use helped him overcome this problem.
Danny said his reason for using methadone was that after being involved in the
criminal justice system for the third time he was motivated to stay out of jail. He stated
that he supported his drug habit by using his income and later engaging in some illegal
activities. He reported that he did not feel his gender or race impacted his treatment
experience. He reported that he wants to remain sober, and his goal is to wean himself off
of methadone.
Anna
Anna is a 55-year-old divorced White female who had been involved with
methadone for 5 years. She said she lives with a roommate who also attends the
methadone clinic, so they try to keep each other accountable. Because of her medical
issues, Anna reported that she is unable to work and receives SSI. She stated that her
drugs of choice were Fentanyl patches, heroin, hydrocodone 10 mg, and morphine, but
that she was never an intravenous drug user. Anna acknowledged that she sees a therapist
on a weekly basis in an outpatient clinic to help her substance abuse treatment. She said
her drug use began as she was involved with someone who was using different opiates.
She further stated that once she began having some medical problems, she self-medicated
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with various opiates. She stated that once she decided to stop using opiates she had to be
hospitalized due to the physical impact of her withdrawal.
Anna indicated that her medical issues from withdrawing from opiates were the
impetus for starting on methadone. She admitted she was “sick and tired” of using opiates
and the impact they had on her life. She reported that she lied to relatives and friends to
get money to support her habit. Anna stated that her gender or race has not impacted her
ability to receive services, but felt there were times people at the clinic did not make her
feel welcome. Anna said her primary goal is to remain sober and not use again. She also
expressed concern that society is starting people out on methadone too soon. She would
like funding for more outpatient and residential treatment programs before starting
younger people on methadone.
Bernice
Bernice is a 50-year-old single White female who has been involved with
methadone for 6 years. She stated that she is not employed and receives SSI to support
herself. Bernice reported using a variety of opiates, including heroin, hydrocodone 10 mg
pills, and methadone 5 mg pills, all of which she stated she obtained off the streets, but
said she has never been an intravenous drug user. Bernice reported previous involvement
in classes to help her understand her drug history. She also said that she would begin an
intensive outpatient treatment program soon. She said her opiate use began to help her
with pain management and said that part of her reason for using methadone is to help her
with her pain management.
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Bernice stated that her reason for using methadone was two-fold: pain
management and she too was “sick and tired of feeling sick and tired.” When she began
using opiates, she was working and supported her habit by using her income. She also
reported stealing from her family, and this behavior caused some strains in her
relationship with family members. Bernice said her gender or race has not impacted her
ability to receive services for her opiate addiction, but at times she felt that clinic workers
did not treat her with dignity and respect. Bernice stated that her goals are to remain
sober, improve her relationships with her family, and begin developing a relationship
with her grandchildren. She also stated that she would like to be treated with dignity and
respect and feels that due to being an older person addicted to opiates she is not.
Rex
Rex is a 53-year-old married White male who has been involved with methadone
for 8 years. He stated that he lives with his wife and their children in an apartment and is
employed. Rex reported using a variety of opiates such as heroin, OxyContin, and
Fentanyl patch. He also admitted a history of IV drug use. Rex stated that he had no
previous treatment experience before starting methadone. He has been involved in NA
but reported no sponsor or other support. Rex’s opiate use began as a way to manage
some pain, but it got out of control. He stated that he has also had to deal with some
losses in his life, and the opiates temporarily addressed his depression.
Rex said his reason for starting methadone treatment was that his son told him
that unless he got help, Rex would not see his granddaughter. He also stated that his wife
became upset with his behavior and threatened to leave him. Rex admitted that he used
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his income to support his habit in the past and did not pay his bills. He said that he did
not feel his gender or race impacted his treatment experience. He stated that his goal is to
remain sober and improve his relationship with his family.
James
James is a 55-year-old single White male who reported being involved with
methadone for 20 years. He lives with friends, one of whom is also using methadone to
maintain his sobriety, and they support each other. James reported using a variety of
opiates such as heroin, OxyContin, 80 mg, morphine, and Demerol, 50 mg which he took
from people who were taking the medications for their pain management. He has also
been an IV drug user. James admitted that he has been in residential and outpatient
treatment to address his opiate addiction. He stated that he began using opiates as he
wanted to be part of the crowd at the time and found that he could not stop.
James said he began using methadone for his opiate addiction after he saw several
friends die from an overdose and realized it could happen to him. He also stated that he
was “sick and tired of being sick and tired.” He said he was tired of using needles and
sick of the behavior he engaged in to support his habit. James stated that he supported his
habit by using his income and hustling others for money for his addiction. He stated that
he did not feel his gender or race impacted his treatment experience. He said his goal is to
remain sober and wean himself off methadone.
Themes Derived From Data Analysis
The purpose of this study was to explore the experiences of older addicts and their
use of methadone to maintain their sobriety. To gather significant meaning from the
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formal interviews, I used van Manen’s (1997) selective highlighting technique. This
particular data analysis approach allowed me to identify key portions of the text and
highlight them to find specific themes. Initially, text highlighting was done in the
transcriptions, but I also highlighted the salient text in NVivo 11 during the final data
analysis.
As the data analysis process unfolded, I identified certain thematic statements for
each distinctive meaning that I discovered in the transcripts. Van Manen (1997) indicated
that themes are statements or thematic statements that sum up each major portion of the
text and that present a special facet to the overall understanding of the phenomenon. Van
Manen saw their development as being distinctive in qualitative methods. Using NVivo
11 allowed me to link significant text with essential themes. This process of linking
themes that NVivo 11 recognized further illustrated the iterative nature of theme
development. Each time I reviewed the transcript, I found new linkages and expanded my
perception of each essential theme.
After completing my analysis, I identified five main themes: relationships with
others and how methadone has impacted these relationships, attitude of being an older
methadone user, mental health stressors related to being an older methadone user,
attending the methadone clinic daily, and needing other treatment besides methadone to
address their opiate addiction. Table 3 shows the complete list of the themes, the number
of sources each theme came from, and the number of times each theme was referred in
the participants’ discussion. Themes were derived from eight interviews. All participants
engaged in the process and provided additional information when asked for clarification.
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Table 3
Final Themes With NVivo 11 Data Analysis Summary Demographics of Participants
Number of sources
from which each
theme was derived

Number of references
across all sources

Relationships with others and how
methadone has impacted these
relationships

8

16

Attitude of being an older methadone
user

8

20

Mental health stressors related being an
older methadone user

8

22

Attending the methadone clinic daily

8

36

Needing other treatment besides
methadone to address their opiate
addiction

8

18

Themes

The following sections include the interview content that related to the major
themes. Throughout these sections, quotations are used as evidence of the themes. These
quotations are not meant to serve as exhaustive examples of the influential factors that
were shared during the interviews. Instead, the quotations are intended to give the reader
a flavor of the thoughts the participants had about their lived experiences regarding
methadone use and some of the actual experiences that motivated them to get sober or
made it difficult for them to maintain their sobriety. The quotations serve as a textural
description of the participants’ lived experiences. The quotations that detail actions that
were taken or how different behaviors were manifested in their lives serve as a structural
description of their lived experiences. The collective narrative summary was constructed
to highlight the essence of their needs as consumers of addiction therapy.
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Methadone’s Impact on Participants’ Relationships with Others
Several study participants shared concerns about how their addiction has affected
their families, especially their children and grandchildren. All participants spoke to the
point that they, like other people, are human and have flaws. There was a concern that
due to their addiction, others saw them as being extremely weak and unable to resolve
issues in their lives. This idea appeared to be especially true for the male participants.
Danny spoke openly about his struggles with opiates and needing methadone to remain
sober. He stated that others had indicated to him that people who need methadone,
particularly older adults, were simply trading one drug for another.
My family and friends do not know that I am taking methadone. I feel they would
see it as me just using another drug. I won’t tell my family that I am using
methadone until I am using less so that they won’t judge me. When I became
addicted to OxyContin, and I was struggling to try and get sober, my family and
some friends did not want me around. Their view on addicts was that I would
steal from them to support my habit. I couldn’t tell them that I was hurting both
physically and emotionally as I felt they abandoned me.
Bernice provided information suggesting that she received mixed support from
her family and friends due to her involvement with methadone. She spoke of how some
of her family supported her being on methadone while others felt that she needed to end
her dependency on other drugs.
Some of my family thinks that it is good that I am using methadone to treat my
addiction, while I have some who have an issue with it feeling that I traded one
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drug for another. They thought when I was hurting, I should find a way to suck it
up and be strong. I was a wife and mother and wanted to be there for my family,
but could not find a way due to my drug use.
Anna, who has been struggling with her addiction for over 20 years, stated that it
was difficult for her to be open and honest with her family about her addiction, especially
being a female.
My family treats me like I am still on street drugs. If my family sees me using
methadone, they treat me like I am no good. They said that if I wanted to stop
using drugs, I would get off with no problems. They also saw methadone as being
something that is short term and don’t understand that without methadone I could
return to my drug of choice. Because I am a woman, I am supposed to know
better and should be the caregiver for others and not have others take care of me.
Nancy, who spoke of her concerns about needing methadone to stay alive, shared
how her family blames her for other family members becoming addicted to drugs and
stated that her relatives wish she did not use methadone.
My mother and other relatives hate me being on methadone. They do attach a
stigma to being on methadone. My family blames me for my daughter and others
becoming addicted to drugs and needing methadone. Some family members think
that I am using methadone as a way to continue my drug use and get high.
When Elizabeth spoke about the importance of family, she talked about it from a
self-need approach. As a person who was involved in the criminal justice system due to
her addiction, she learned that she sometimes cannot depend on others for care.
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Some of my family members see people using methadone as being IV drug users.
When I struggled in the past, I could not be honest with them for fear of being
rejected and ostracized. I had to find treatment on my own and be able to answer
their questions about addiction. I found it necessary to pull back from others for
some time to reflect, refocus, and reenergize to continue working on my recovery.
William also indicated that his family does not support him needing methadone to
work on his recovery. He further indicated that he did not seek support from his family
for his recovery and reported that he is on his own when he works his recovery.
My family sees me using methadone as a way of getting high. They think that I
should just be able to stop on my own. I don’t get my family and others involved
in my treatment, I work it by myself. I don’t think they understand the pressure
and that comes from me trying to be sober. My family is unsure what to say or
how to help at times, but continues to tell me not to use.
There were two exceptions to this position. James indicated that he receives a
great deal of support from his family but not his friends. He indicated that his family
supports his recovery efforts but stated that he has hidden his issue from some of his
friends.
My family is all for me using methadone to stay sober and not return to my
previous behavior. My family is also very supportive of my treatment, especially
my mother. I know that if I did not have her support, I would become upset and
probably use again. I have not told my friends about me using methadone because
I feel they would judge me too much due to my previous behavior. They
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categorize being on methadone as hanging out with other drug addicts and not
doing anything about my life. I don’t think they understand the need to be on
methadone and that my addiction is a disease. When it comes to people other than
my family I feel that I am fighting a losing battle trying to get them to understand.
Rex indicated that he receives support from his family and friends as it relates to
him being on methadone and not using. He acknowledged that he seeks his family and
friends’ to help him remain sober.
My family and friends are okay with me using methadone. They saw how I was in
the past and feel that methadone has had some positive effects on me. The people
who don’t know about how methadone works are uneducated about addiction and
its impact on people’s lives.
All study participants provided examples of their humanness and how others find
it difficult to view them as being less than human or not having others accept them as
they are. This common theme speaks to the need for older methadone users to have
healthy relationships with family and friends without feeling that others are judging them
or placing unrealistic expectations on them.
Attitudes Related to Being an Older Methadone User
Participants’ attitudes appeared to be mixed relating to older opiate users needing
to be on methadone. Several of the women interviewed had a negative attitude about
being on methadone at their age while most of the men reflected a positive attitude.
Nancy reported feeling upset that no one talked to her about how long she would
be on methadone and some of its physical effects on her.

87
I wished someone had warned me about the ultimate downfall. I would have
never started using methadone had I known that I would be on it forever. I would
have loved it if they had advised me about why I needed methadone for as long as
I have taken it and I might have changed my mind.
Nancy also spoke about the physical and emotional rollercoaster she felt being
on methadone. She acknowledged that despite needing methadone to maintain her life,
she was unhappy about depending on it, and said, “I wished someone would have warned
me about the withdrawals when methadone wears off, I would never have started using
it.”
Even though Bernice acknowledged that it has been hard for her to remain sober
in the past, she has problems with not being able to eliminate her need for methadone.
To me methadone is more addicting than other drugs, and I wish I had never
started it. I feel like being on methadone has made me age more and sometimes I
feel that this drug should be for younger people.
William also acknowledged his displeasure about needing to take methadone.
Even though I need it to help deal with my physical pain, I do not like being
dependent on methadone. I wish that they would counsel you or tell you about all
that it takes to maintain your sobriety while, on methadone, I may have made a
different choice. As you get older, it becomes harder to get along without the
drug.
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Danny indicated mixed feelings about being on methadone. He spoke about his
struggles being an addict for as long has he has been, but also the importance of being on
methadone.
Methadone makes me feel like I have lost a lot and now it is catching up to me.
Methadone has also helped me stay straight. I see methadone as a tool to get the
most out of myself and it has also helped treat my chronic pain.
Anna also expressed some mixed feelings about being on methadone. She saw
methadone as a lifesaver but also a curse.
Methadone has saved my life and I may have been dead without it, but it has also
put some serious stress in my life. When I don’t take the methadone, I will go
through some significant withdrawal. I need to go to the clinic daily to get my
dosage and I hate it. I can’t go anywhere due to needing to be dose daily.
Others expressed a more positive attitude about the importance of being on
methadone at their age. Elizabeth stated that as she has an addictive personality, and
recognizes the need to take methadone.
I am grateful to this means of treatment, especially for someone my age. I have
tried other medical treatment, including Suboxone, but I had trouble transitioning
and eliminating other opiates out of my system when taking Suboxone.
Methadone was the only medication that has worked for me.
Rex stated that it is difficult for someone his age to connect with other people of
similar ages and with similar experiences who have also struggled with opiate addiction
and needing methadone. He said, “It has helped me become more stable. I feel more
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content and can be more active in society. Methadone has helped me reconnect with my
family as I am now more involved with my family.” Rex stated that before taking
methadone, he felt as if he was alone at times as an addict and that others would not want
to be around him or want him around their family.
James also acknowledged that at his age he struggles with feeling alone in his
battle with his opiate addiction. He said, “I would rather be on methadone than be out
hustling. At my age, I can’t do what I did in the past, so taking methadone has saved my
life.”
Five participants directly expressed issues with taking methadone at their age.
One participant who reported not having a problem being an older methadone user at her
age said she felt it important to use whatever tool is available to overcome one’s
addiction. The importance of her needing methadone was still evident in her response to
trials in her life.
Mental Health Stresses
As older methadone users, many participants expressed that there were certain
stressors and experiences that came with being on methadone. The areas of life that were
affected the most varied in intensity and frequency. Participants who shared concerns
about stressors and experiences indicated that others cannot comprehend the gravity of
maintaining their recovery.
For Nancy, the mental health stressors and experiences related to being an older
opiate user centered on a myriad of emotions that she experienced and dealt with on a
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daily basis. She spoke openly about the emotional ups and downs that she has to address
while trying to help her daughter balance her emotional state.
During different times when I was struggling with some of my issues, I could not
address them as my daughter would call me upset because of problems with her
boyfriend. I know that I have a co-occurring disorder and it is difficult for me to
talk to others about my issues. I find it difficult to trust others because I have been
burned so many times in the past. We do need help with our self-esteem for using
methadone at our age.
Elizabeth shared how her mental health problems are related to her poor
relationships with others. She also indicated that being over 50 years of age and knowing
that she needed to make changes in her life has caused her some mental health problems.
When you feel like you let others down you begin to feel some stress and realize
there is no magic wand to fix your problems. A lot of times older addicts are
misunderstood and so it becomes quite stressful. There are times I feel that trying
to maintain my sobriety can feel overwhelming and I need to find someone I can
talk to.
Saying no to others has been a major mental health problem for Anna.
For many addicts, including myself, we want relationships with people who
understand us so we hang out with the wrong people. As I want someone to like
me, I am willing to do nearly anything. I feel that if I don’t I won’t have anyone
who will like me. I become depressed when I say no and I become depressed
when I do something I should not. In the past when I became depressed I would
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use. Being an addict I feel that others may judge me for my past behaviors and not
want to listen to my story.
Bernice also shared how being an older methadone user has caused her some
mental health issues and feelings of depression. She acknowledged that she has found it
difficult to share with others and that she feels that when she needs to talk, people will
find all sorts of excuses not to be there for her or do not have the time or want to engage
with her at an intimate level.
You can always try to get some help from somewhere, but a lot of people look
down on you for that. Some people think we should know better, but it would be
good to get help from others. It becomes a problem so you feel like you are all by
yourself.
Danny also acknowledged that he struggles with depression, but stated that he
turns to his faith to help him through his problems. He said, “For me when I feel down, I
go to church and try to retain my faith in God.” He shared a personal experience of seeing
someone overdose and struggling internally as he could have done more to help his friend
or look for signs that his friend was in trouble.
I was devastated when my friend died, but did not know how to deal with it
except continuing to use. There was a definite weight of having to come to terms
with being an older addict when you see someone die from doing the same thing
you do. I think one of the challenges for us an older addicts is to recognize the
mental health problems within yourself. You see others misbehaving and you
can’t help them because you are doing the same thing.
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Older addicts face many mental health stressors on a daily basis. Five study
participants shared examples from their lived experiences that have affected them as
being an older person needing methadone. All of the women in the present study reported
some form of a mental health problem related to being an older methadone user that
could speak to the added stress of being an addict. Danny shared the emotional loneliness
that he experienced for not feeling that he connected with his family and how some
turned their back on him when they learned he was addicted to different opiates.
Although all participants expressed concerns about not being viewed as a human
who has hurts and pains, most admitted that being seen simply as an addict has not
allowed them to openly display their hurts and troubles. There was an inherent pressure
of at least appearing healthy because they struggled to find emotionally safe people they
could confide in.
Attending the Methadone Clinic Daily
Having to attend the methadone clinic daily to obtain their methadone was an
issue evident throughout many participants’ narratives. Not being able to have a normal
life was not lost in this collection of older methadone users. For the participants in this
study the inability to spend significant time with family and friends affected them having
a normal life. Several participants spoke of being fearful of being penalized if they
missed time at the clinic.
Anna was very outspoken about having to go to the clinic on a daily basis for her
methadone. She expressed frustration about not being able to spend time with her father
who lives outside the area and has some significant medical issues.
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I wished that we could find other ways to get our dosage. I feel as if I am chained
to the clinic and I cannot go anywhere for a significant period due to needing to
go the methadone clinic every day. I would like more of a life.
Bernice talked about feeling embarrassed having to go to the clinic and get
permission from others to feel better. She explained that she felt that the clinic staff and
others may treat her like a child and said, “I sometimes feel like they treat me as a child
and not as an adult.” Bernice spoke of her frustration of having to get herself ready to go
to the clinic every day along with the stigma of being seen at the clinic. She indicated that
due to her physical problems she struggles to have to go to the clinic every day and said,
“I would like to get methadone from my medical doctor as he has a better understanding
of all of the medications I need for my life.”
Elizabeth expressed how she felt the system does not trust her by requiring her to
come to the clinic daily.
I know that there are consequences if I was to relapse. Making me come to the
clinic every day does not guarantee I won’t do anything I shouldn’t do. I need to
do be able to do other things with my life besides worrying about getting to the
clinic every day.
For James, going to the clinic daily was very troublesome. As he does not have
his own transportation he has to rely on people to get him to the clinic and does not like
how others look at him being an older user.
Even though my family wants me to get and stay sober, I know that they get
frustrated about having to take me to clinic all the time. I also hate asking people
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for a ride and wish that I could feel like I have regained their trust. I feel people
look at me differently because I am much older than what others expect people
who are addicts look like who use methadone.
Nancy also felt that going to the clinic daily at her age made her feel that the staff
did not trust her. She also talked about the difficulty of her family believing that she
needs to attend the clinic daily.
Trust is an important issue for me and when I have to go to the clinic daily, I feel
as if I am being put down for being an older addict. Even though my family sees
methadone as medicine, they don’t see why I have to go every day as other
people needing medicine are able to get it and go home.
William talked about how having to attend the clinic daily affects his ability to
work. He indicated that he would like to have a normal life and be able to show others
that he can care for himself. For him attending the clinic daily prevents him from being
able to work overtime or different schedules. He said, “I would like to work first shift or
get promoted, but I can’t because the times I would have to work would interfere with me
getting my meds.”
Six participants shared their frustrations about going to the clinic on a daily basis.
These participants all shared their negative experiences that spoke to them having to
ensure that they will not misuse their medication. The need to attend the clinic daily
appears to add to the stigma of being an older methadone user and the feeling of being
alone and isolated.
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Needing Other Treatment Besides Methadone
The need for additional treatment services for older and younger opiate addicts
was not lost on study participants. Participants stated that for additional treatment to take
place it was important that those who fund the programs understand and see that
methadone by itself is not a cure for people’s opiate addiction. Some participants
identified what they felt would be appropriate treatment modalities for older opiate users.
Additional treatment for Nancy centered on the ability to find someone she could
trust.
I need to talk to someone about some of my past issues that contributed to my
addiction. My problem is that I have tried counseling in the past, but I have felt
betrayed by some people. “I know that other addicts and I need more than just our
daily dosage, but I am not sure how to go about getting it.”
She also indicated that therapists need to talk to clients about the clients’ needs and not
assume that as the therapist they know everything.
Elizabeth expressed her gratitude for being able to talk to someone about her
problems and other issues that did not solely include using methadone.
Treatment providers in the community have knowledge of additional resources for
addicts. Working with a case manager, I was able to get decent housing. The other
thing is that I know there is someone who will hold me accountable if I make a
mistake, but not make me feel as if I was the worst person in the world.
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Elizabeth said that one thing that helped her talk to her therapist was knowing that the
therapist was duty bound to keep the secrets of others, which made her feel safe talking
about issues that she did not feel comfortable sharing with family and friends.
Outpatient treatment is something Anna values and has used to deal with some
significant problems in her life. She shared how in most instances she needed someone
who forced her to talk and share thereby helping her overcome past issues.
For me it has been difficult to share and I know that I have some issues from my
past that need to come up. If they don’t I could use again. I need a person who
will push me to talk more about my addiction and what I went through. I need to
talk about what I lost and if I go astray, they need to hold me accountable.
Bernice stated that involving older opiate users in additional treatment is
imperative for their recovery. When asked what she could get out of therapy she said it
would help her improve her self-esteem.
I know that I have a lot of past issues that have impacted my life. I have been
feeling depressed for a number of years and need to find out why so that it does
not continue to cause me to want to return to using again.
For Bernice, treatment centers on feeling safe and being able to share. She also stated that
being able to talk and speak out about her life helped ensure that she does not return to
some old negative habits.
James said he is aware that treatment besides methadone would help him in his
recovery but said that he has not found anyone he feels he could trust.
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I know that I need other treatment as it will help keep me sober. I am selective
about what I will use as I need to know that I can trust the person or the program.
I would like to find someone near my age who also has experienced issues with
addiction. I need to know that they can understand what I have gone through.
Five participants provided specific reasons for being involved in additional
treatment. The most common themes were working with a therapist who is empathic,
who will treat them with dignity and respect, and who hold them accountable if they were
to relapse.
Summary
Participants in the present study discussed and shared a multitude of experiences
and issues that they face on a regular basis when dealing with their need to use
methadone to maintain their recovery. Data analysis resulted in five themes. These shared
lived experiences or themes help broaden the understanding of the views, attitudes, and
barriers for older methadone users. A discussion of study findings, limitations,
recommendations, and social change implications is presented in Chapter 5.
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Chapter 5: Discussion, Conclusions, and Recommendations
The present study’s findings contribute to the understanding of the lived
experiences of older methadone users addicted to various opiates and their thoughts about
needing methadone. In this chapter, I summarize and expand on the results I presented in
Chapter 4, discuss the findings in comparison to existing help for older methadone users
in the literature review, examine the study’s strengths and limitations, and offer directions
for further research based on data from this study. It is also my hope that findings from
this study will stimulate positive social change by increasing the education of addiction
professionals and funders who have a vested interest in creating relevant interventions for
this particular population.
The purpose of this phenomenological study was (a) to acquire an in-depth
understanding of the phenomenon of older methadone users, (b) to elucidate and describe
participants' experiences of addiction and treatment using their own voices and
perspectives, (c) to extract and develop themes from the data, and (d) to interpret
participants’ lived experiences and meaning constructions using a theoretical framework
of addiction. This research study was conducted to address a gap in the literature on older
methadone users, a population that has not been the subject of many studies. I hoped that
findings generated from the study could inform therapeutic interventions designed to
improve the treatment experience for older methadone users.
Through this phenomenological study, the lived experiences or unique
phenomenon of the treatment needs, views, and attitudes of older methadone users was
established. Participants all stated that treatment providers treating them with dignity and
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respect was important and sometimes overlooked. The idea of decreasing their current
methadone dosage was not identified as an issue that current treatment providers
encouraged or felt older methadone users needed to consider. Instead, current dosage was
valued and supported, although accessing actual care was more difficult for many reasons
and rationales.
Male and female participants all identified as being opiate dependent and needing
methadone for their addiction but reported that they were not given the opportunity or
social permission to be seen as having flaws. This failure on the parts of others to accept
their defects did not prevent them from seeking out care but made it more difficult.
In the fall of 2015, eight methadone users ages 50–55 years were recruited from
the greater Grand Rapids, Michigan, area to participate in the present study. The
participants agreed to share their stories about being on methadone at their age, their
history of opiate addiction, and their treatment experience. As a result of extensive
qualitative data analysis, five prominent themes materialized from the study. These
themes were (a) relationships with others and the impact methadone has on these
relationships, (b) attitudes of being an older methadone user, (c) mental health stressors
related to being an older methadone user, (d) attending the methadone clinic daily, and
(e) needing other treatment besides methadone to address their opiate addiction. Through
these five themes, the lived experiences of older methadone users and their treatment
needs, views, and attitudes about being an older methadone user were explained. Based
on the participants’ responses to the interview questions as well as the constructed
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meanings and interpretations that emerged from the data analysis process, answers to the
research questions and a discussion of findings for each identified theme were as follows.
Hermeneutic Reflection
As the participants reflected on their lived experiences, their perceptions of what
it means to be an older methadone user began to materialize and form. Interpreting the
addicts’ productions of this enigmatic, socially constructed phenomenon, I observed that
being an older methadone user means understanding and developing the need to rise
above their previous hardships, which for study participants includes the challenge of
trying to maintain their sobriety along with developing a normal life. Participants’ need
for methadone and their disappointment in needing the medication have caused them
mixed feelings about their current treatment. Having survived their addiction, the
participants discovered the need to have others involved in their treatment experience
recognizing they cannot remain sober on their own. The participants in this present study
understood that their addiction has caused them problems in their lives and has also
caused them to rethink their relationships with others.
Research Questions and Answers
This hermeneutic phenomenological study was guided by two main research
questions and one subquestion:
•

RQ 1: What are the lived experiences of opiate users ages 50–55 years who take
methadone to manage their addiction?

•

RQ 2: How do opiate users ages 50–55 years relate their particular experiences to
the idea of recovery?
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•

Subquestion: How do these same opiate users on methadone remain consistent in
their methadone treatment so that they can stay in recovery?

Research Question 1
As the study findings illustrate, the participants ascribed meaning to their
traumatic experiences regarding finding that they need methadone to have a life. The
participants also indicated an increased dependency on others such as family and friends,
a need to increase their self-worth and a need for personal growth, and a greater
dependence on a treatment program. The most significant, compelling, and integrated
meaning participants drew from their lived experiences is that their dependency on
methadone was based on previous issues. In other words, the participants believed poor
decision-making in the past had contributed to their dependency on methadone. As the
accounts reflected in Theme 2 revealed, the participants’ lives became more
consequential and focused through their telling others of their pain and suffering.
Because of their live experiences, the majority of participants perceived that younger
methadone users need to listen to them and understand the impact of their poor decisionmaking.
Research Question 2
Based on the participants’ meaning-making constructions, the participants’ idea
for needing recovery was the linchpin that held their unstable and complicated lives
together. All participants endorsed the belief that recovery supports them during times of
crisis and inflamed disturbance. The participants’accounts, the information indicated that
they would not have lasted, let alone improved, without being in some type of treatment.
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Although their commitment to recovery was tested when participants were being
tempted, they reported that once they began using methadone participants never lost sight
of the importance of being in recovery. As Elizabeth stated, “Recovery saved my life and
I would not be here if I had not begun to believe in it and work the methadone program.”
Consequently, as the participants reflected on their lived experiences and as they gained
awareness and perspective about recovery, their belief in the need for recovery grew
stronger and more resilient.
Follow-Up Question
All participants acknowledged that despite their feelings about taking methadone,
they do not miss an appointment. These participants stated that if they missed an
appointment they could experience some physical and emotional withdrawal. These
particpants also indicated that they would be expelled from the program and have to start
all over again. Several participants expressed a desire not to have to attend the clinic
every day. Some participants stated they wished there was a way to get the methadone
treatment without going to the clinic daily. Anna stated that she felt chained to the clinic
and could not spend time with others without having to report in. William indicated that
he did not think the need to be involved in a recovery program is necessary for him to
stay sober.
For the most part, all study participants readily identified the importance of being
in recovery at their age in at least some aspect. In light of their problematic lives, most
participants found important meaning in being involved in recovery that includes
additional support. With the possibility of relapse, the participants held firmly to their
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belief of being in recovery to keep them from returning to previous behaviors that were
problematic for them.
One advantage that clinic attendance provides is consistency. According to
Madden, Lea, Bath, and Winstock (2008) public clinics provide structured treatment that
oversees the client’s dosing and access to medical staff and other support like case
management, if needed. The negative of not attending the clinic daily is that there is no
guarantee the participant will take the dosage as prescribed. Attendance offers structured
treatment including supervised dosing and access to medical specialist and case
management support. Takeaway doses are not dispensed routinely at most clinics and
treatment is provided at no cost to the client.
The concern is creating and sustaining medically dependent opiate users. Despite
attending the clinic daily, the participants indicated that no one has discussed with them
the idea of reducing their dosage after some time. Treatment providers are now being
paid for the number of people they treat and may not consider transferring clients to other
treatment providers, i.e., primary care physicians. Furthermore given the growing rate of
opioid-dependent patients seeking psychosocial treatments there is a need to evaluate
alternate interventions.
Thematic Findings
Theme 1: Methadone Impact on Participants’ Relationships With Others
Study participants talked about how much their addiction has impacted their
relationships with others. Several voiced disappointment and guilt about the effect their
addiction has had on their families. The women in the study were more expressive of
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their guilt feelings than the men. Two female participants talked about feeling guilty
about how their addiction forced them to eliminate any contact with their family and
friends. These females acknowledged that they chose their opiates over their children and
other family members.
Another issue for study participants was trying to reestablish relationships with
family and friends that had become strained due to their addiction. Several participants
indicated that they have been working on trying to restore themselves with family and
friends but that lack of trust interfered with that process. Seven participants indicated that
it was important for older addicts to understand that their addiction impacts them and
others as well.
Similar to the previous research of Hamilton and Grella (2009), findings from the
present study indicate that some older opiate addicts have regret and shame when it
comes to their addiction and their relationships with others. Present findings showed
some difference between genders in that male and female participants expressed similar
feelings about the need to improve or reestablish family and social relationships. The
women in the study indicated that they wanted to improve their relationship with their
family members, while only two of the men acknowledged the same. Doukas (2011)
noted that as addicts age, their immediate support system decreases as their family and
friends move away or die. Many older addicts may isolate themselves from others due to
their drug use thereby reducing their support system. Developing and keeping a healthy
support system is important for anyone who is involved in substance abuse treatment, but
this is particularly important for older adults in the present study.
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Theme 2: Attitude of Being an Older Methadone User
As reported in Chapter 4, study participants appeared to have mixed feelings
about needing methadone at their age. Several of the women had a negative attitude about
being on methadone at their age, while the men reflected a positive attitude. The female
participants acknowledged trouble dealing with the stigma of being older methadone
users. Some identified with issues of health, negative social relationships, and other
stigmas associated with aging. Combined with needing methadone for their addiction, the
participants reported feeling that society takes a dim view of them still needing support.
One issue that was evident throughout the interviews was the participants’
concern about becoming addicted to methadone and having to experience withdrawal if
they stopped taking it. Seven participants indicated that they were upset about starting
methadone as they now are hooked on it like their opiates. These seven participants all
agreed on the need to take methadone to help block and reduce the craving for illicit
opiates. When asked what the chances of reducing their dosage were, six participants
reported they did not feel they could for fear of physical and psychological withdrawal.
One attitude participants expressed about being placed on methadone was
treatment providers failing to inform potential clients of the risks of taking methadone.
Two participants expressed concerns and anger about the lack of education provided to
them regarding any problems with taking methadone. Four participants stated that they
did not realize that they would need to take methadone for as long as they have been
taking it. Some participants in the study indicated that methadone programs did not
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inform them that opiate addicts would need to take methadone for the rest of their lives
and that their options were limited in treating their opiate addiction.
Theme 3: Mental Health Stresses
Mental health stressors and experiences related to being an older methadone user
were prevalent in participant comments. Being an older methadone user was described as
being stressful most of the time. Study participants could not stress enough the emotional
and mental weight and burden that comes with needing methadone to feel safe and
secure. Being on methadone at their ages was described as tiresome and, at times, a
burden.
Participants who have wanted to maintain a relationship with family members
while using methadone needed to address mental health and stressful issues. These
participants were not only responsible for maintaining their recovery but also felt a need
to assure family members that they could be trusted to take care of finances, to be a good
parent, and to ensure the family’s safety and welfare. Study participants identified the
emotional swings they experienced on an average day. These participants acknowledged
they could start their day thinking about getting to the clinic for their daily dosage and
then worry about improving their relationships with others and improving their selfesteem.
Two of the women in this study expressed a need for mental health treatment to
address past issues that were an impetus for their drug use. These issues were relationship
problems, physical abuse, and feelings of rejection. One of the men in the study
expressed concern about how the stress and experiences he had to deal with affected
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members of his family. He understood that even though he was the addict, his behavior
had an impact on his wife and children.
Although already dealing with the stigma of being an IV drug user, of aging, and
of being on methadone treatment, many participants faced the stigma of mental illness.
Like previous studies such as those made by Connor and Rosen (2008) and Semple,
Grant, and Patterson (2005) regarding the stigma of mental illness, present study findings
also showed that despite the need to address their mental issues, older methadone users
were reluctant to talk to their family and friends about them. As previously stated,
participants felt distinct pressure from family members to be perfect and not be affected
by stress and life struggles in the same manner as those who are not addicts. Although the
participants desired to be viewed as human, there was also pressure to maintain an image
of being “healthy and fine.” This pressure made it difficult for participants to seek help,
as they feared that they would return to their previous drug use behavior if they failed.
Study participants made it clear that mental health treatment is important and a
needed part of good self-care if older opiate users are to operate in a healthy manner
when facing stressful situations. In talking about what qualities were most desirable in a
therapist, participants wanted someone who had experienced addiction, relapse, and
cravings. These qualities were approached from multiple perspectives. One participant
compared the need for the therapist to understand cravings and other issues associated
with being an addict with physicians who should be well educated in patients’ medical
needs. Two participants commented on the need to know that the advice or guidance they
received would be based on the 12-step program. According to Kothari, Hardy, and Rowe
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(2010), the therapist’s approach for treatment in helping the addict develop a
commitment to staying sober and being consistent with their treatment goals is vital to
developing a strong alliance.
Theme 4: Attending the Methadone Clinic Daily
Unlike health policies in other countries, the United States does not have a
specific policy regarding drug treatment service delivery. Many study participants
supported the idea of obtaining their medication without having to attend the clinic on a
daily basis. Similar to previous study findings of Treloar, Fraser, and Valentine (2007),
participants indicated the benefits to them would be greater convenience, saving money
on travel, reducing the possibility of others learning about their involvement, and
increasing the ability to work. When starting a methadone treatment program, clients new
to the procedure are expected to come to the clinic on a daily basis to secure their
medication. One concern acknowledged by present study participants was the difficulty
in getting to the clinic on a daily basis. Participants’ feelings appear to be supported by
previous study findings that programs requiring long-term commitments for daily clinic
attendance had difficulty retaining clients in treatment (Bell, Dru, Fisher, Levit, & Safraz,
2002).
Six participants expressed frustration about having to go to the clinic daily. The
majority of participants felt that attending the clinic daily reflected a lack of trust in them.
When asked about the possibility of relapsing, participants indicated that they would be
more than willing to take a drug test to ensure that they are not using illicit drugs such as
cocaine or marijuana. One participant noted that she was well aware of the consequences
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should she violate her agreement not to use illegal or illicit drugs. It should be noted that
urine drug tests will identify methadone as an opiate, but not an increase level of the
opiates. Participants’ responses regarding service delivery and the clinic environment
reflected a strong desire for having flexibility in going to the clinic and receiving their
dosage as well as in clinic hours of operation. Their concerns were similar to those in
other research regarding methadone treatment (Madden, Lea, Bath, & Winstock, 2008).
Study participants seemed acutely aware of how clinic workers and others
perceived their desire not to attend the clinic on a daily basis. Participants expressed
concern that they did not always make the best decisions when it came to ensuring their
methadone use. Participants shared stories of how some older users who were allowed to
take their medication unsupervised did not always comply with the rules thereby forcing
the clinic and others to reevaluate the takeaway program. A major theme derived from
study participants when it came to not attending the clinic on a daily basis was trying to
facilitate a normal lifestyle and generate a sense of trust in society.
Theme 5: Needing Other Treatment Besides Methadone
Needing other treatment besides methadone was an issue many study participants
expressed throughout their narratives. Not lost on the participants was the need for
additional treatment services not only for them at their age, but also for younger opiate
addicts. Several women talked about their depression and its impact on their addiction.
These women noted that they needed additional services to combat their depression so
they would not seek drugs to treat their former ways of addressing their depression.
Another reason for needing additional treatment was to help with the loss that older
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opiate users have experienced. Six participants reported not being able to work to support
themselves and experiencing some depression due to the loss of friends and associates.
Although all of the participants felt that methadone was helping them with their cravings,
three participants indicated that eliminating their cravings would help them not overdose
like the friends they lost due to their friends’ addiction. Present study findings related to
other issues besides participants’ addiction were similar to previous research related to
co-occurring issues. Minkoff and Cline (2006) noted that when treating people with
addiction and a mental health disorder, both should be treated at the simultaneously and
each one given equal importance.
Participants also discussed needing additional help with medical issues. Research
has shown that medical professionals who work with people with addiction need to be
trained to work with older opiate users who may be presenting with issues besides
addiction (Doukas, 2011; Williamson, Darke, Ross, & Teesson, 2009). All four women in
the present study admitted having some physical problems, and two of the women needed
assistance for their mobility. These women reported due to their addiction they forfeited
nutritional needs, failed to seek medical attention when feeling ill, or utilized prevention
services such as flu shots or other vaccination as they were engaging in drug seeking
behavior. Two of the men stated that they had experienced some physical problems but
had not sought medical attention. All participants noted that it was difficult for them to
see a doctor on a regular basis, as all of the primary care physicians in the area limited the
number of Medicaid patients they treated.
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In the present study, seven participants reported being involved in an NA
program. The particapnts’ reasons for being involved included the support the
participants received from other addicts. Etheridge, Hubbard, Anderson, Craddock, and
Flynn (1997) noted that the increase in NA meeting involvement is due in part to others
understanding the importance of aftercare programs and a decrease in funding for
treatment programs. Despite the 40 years of research on 12-step programs (White at al.
(2013) stated treatment providers should not view 12-step programs as a standalone
treatment.
One issue in the present study that appeared to be similar to those in other studies
was the lack of connecting with a sponsor. Only one participant indicated having a
sponsor or someone in a program to talk to. Five participants stated that the reason for not
having a sponsor was more about trust than availability. Concerns about confidentiality
made it difficult for the participants to seek help as they felt a sponsor would,
intentionally or not, share what was said. One participant valued being able to go to
therapy in a place where he would not be seen by many people because of the premium
he puts on privacy. If participants are involved in a 12-step program, other treatment
modalities should also be such as outpatient methadone (OMT) and outpatient drug-free
(ODF) programs should be included in their treatment plan.
Another issue participants noted was dealing with some negative experiences at
NA or AA meetings. Five participants talked about how some 12-step program
participants, especially those in AA, saw people taking methadone as substituting one
drug for another. As a result, these participants felt as if they were being punished for
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caring for themselves. Although greater 12 step attendance was related to better
treatment outcomes after detoxification, patient attendance and involvement in these
groups did not lead to better opiate use outcomes. Consequently, an important goal of
psychotherapy should be to encourage and maintain NA involvement. However, simply
supporting a psychotherapy patient’s participation in NA fails to result in a unified
treatment approach if the two models of change are not working together in a coordinated
manner.
Limitations of the Study
The present study’s primary strength was its design. The help-seeking views,
attitudes, and barriers for older methadone users are areas that have not received much
research attention. This lack of information influenced the decision to use an empirical
phenomenological framework to better understand the lived experiences of older
methadone users. This form of qualitative research allowed for collecting data through an
initial interview. By conducting in-depth interviews, I built rapport with the participants.
This rapport was conducive to creating an environment of respect and safety that led to
participants sharing deeply personal and revealing information.
Additional study strengths included (a) bracketing of my experiences as growing
up in an addictive family, (b) being an addiction therapist, (c) manageable sample size,
which allowed for greater depth and broader scope of data retrieval, (d) an even
distribution of men and women, which allowed for varying perspectives, (e) the age
range of the participants in that they were all close in age and therefore able to identify
with some similarities while growing up, (f) the semistructured interview protocol to
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minimize researcher bias and allow for participants to explore their experiences as they
saw fit, and (g) a comprehensive analysis.
With this said, it is important to note that results from the present study should be
weighed against several limitations that are typical of qualitative research. First, the
results may not be generalized to larger populations of older methadone users as my
focus was only on elucidating and describing the lived experiences of the eight study
participants. Second, all participants in the study came from the greater Grand Rapids,
Michigan area, and all but one attended the same methadone clinic. Such similarity could
impact the study as those attending the same clinic may have similar responses to all of
the questions.
Third, the sample was fairly homogeneous in that all of the participants were
White despite efforts to recruit African Americans and other minorities who would also
identify as being older methadone users. Therefore, the results may not be representative
of members of a more diverse ethnic or racial groups. To recruit African Americans and
other minorities, Spence and Oltmanns (2011) suggested that the advertisement seeking
participants should be very specific as a general announcement may be viewed with
skepticism in a minority community. Another way to help recruit minorities for future
studies is that older African American should be addressed by their surname until the
researcher is given permission to call the potential participant by their first name. Such
behavior shows respect and sincerity in the African American community. Fourth, the
information gathered for this study was obtained by conducting in-depth interviews and
relied on participants’ self-reporting. As a result, there were no objective measures to
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substantiate their stories or any empirical data as this type of information gathering was
beyond the present study’s scope. I relied on each participant to be truthful about his or
her experience as an older methadone user. Even knowing that they were to receive a
small token of appreciation, all participants appeared surprised and appreciative when
they received it.
Research Recommendations
Based on the present study’s strengths and limitations, some recommendations are
proposed for future research. First, additional phenomenological studies should be
conducted to examine the lived experiences of older methadone users. As discussed in
Chapter 2, there is a significant gap in the qualitative literature about the experiences of
older opiate users who depend on methadone for their addiction treatment. At the same
time, methadone continues to be the primary treatment for opiate-addicted people, and
the number of people needing methadone is on the rise (Bart, 2012; Gossop & Moos,
2008).
Second, while some quantitative studies have been conducted over the past
several years on methadone use and addiction, very few phenomenological studies have
been conducted to specifically examine older methadone users. Moreover, relatively few
qualitative studies have been conducted regarding older methadone users needing to
attend the methadone clinic and how not wanting to attend the clinic daily influences
their methadone treatment. Generally speaking, more researchers should examine the
stigma of being older methadone users and the stigma of having to be supervised while
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taking their medication and how the medication impacts their treatment experience
(Anstice et al., 2009).
Third, future research on the lived experiences of older methadone users should
focus on examining how various mental health diagnoses, family relationships, and legal
status correlates with the treatment modality. Researchers should consider different
coping strategies older methadone users engage in, including NA meetings, spirituality,
and religious involvement. Although all present study participants acknowledged the
importance of having a higher power, none indicated being involved in a specific
religion. Furthermore, research should be conducted on this population’s help-seeking
behaviors. Studies conducted over the past several years have shown that older
methadone users experience some significant losses and exhibit a high degree of anxiety,
low self-esteem, and a feeling of hopelessness (Borelli, Luthar, & Suchman, 2010; GilRivas et al., 2009; Kwiatkowski & Booth, 2003; Wu & Blazer, 2011).
Fourth, research in this area would benefit from a larger study that sampled more
participants and reflected a better racial balance. As previously mentioned, efforts were
made to include African Americans in the present study, but this was not accomplished.
African Americans are reluctant to be in an empirical research due to not trusting
research based on past negative experiences (Coker, Huang, & Kashubeck-West, 2009;
Katz et al., 2009). Generally speaking, African Americans tend not to trust outsiders as
there is a shroud of secrecy regarding the African American culture (Nicolaidis et al.,
2010). By expanding this study, the results could be generalized to a larger population of
older methadone.
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A larger study would potentially allow for more themes under the views domain
to be flushed out and explored, which would further impact how clinicians understand
and work with older methadone users. A larger study would also allow for further
exploration of issues such as confidentiality in the community and in the clinical
relationship. Finally, a larger study would also potentially carve a well-rounded depiction
of the preferred characteristics of clinicians who work with this population. From a larger
study, a treatment model could be developed through a qualitative grounded theory
framework. As older methadone users are better understood in their cultural context, a
model that addresses and understands older methadone in that context could prove
monumental. Older methadone users must deal with the reality of being an opiate addict
in the addiction community as well as individuals unable to share their stories with
others. This unique intersection requires sensitivity to ethnic, spiritual, and cultural
issues. A model in which it were possible to juxtapose these key identity factors for this
population would be a model with the power for addressing stigma and making mental
treatment more accessible and welcoming to older methadone users.
A study on the impact of good mental health care and wellness in older
methadone users and how these factors influence the mental health and emotional
wellness of their families, especially their children, would be powerful. Many participants
in the present study shared concerns about how their addiction had affected their
relationships with family members and how their children have engaged in some drug use
themselves or cannot relate well to others. Further examination of relationships with
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family members may impact older methadone users’ decisions to seek help if they
believed that it would impact their family in a positive manner.
Implications for Social Change
Some important implications emanated from the present study's findings related
to research methodology, the practice of professional counseling, and engendering
positive social change at the micro- and macrosocietal levels. Regarding methodology,
results from the present study add to the knowledge base of qualitative research
concerning older methadone user. This study was undertaken, in part, because a
significant gap existed in the qualitative literature about dosage and the need for daily
clinic attendance for older methadone users in the United States. The majority of the
research I identified in Chapter 2 was done in Europe or Australia.
To date, few phenomenological studies have been conducted on the lived
experiences of older methadone users in general and the lack of ongoing treatment
outside of the daily dosage they receive. Moreover, the intrapsychic and sociocultural
factors impacting low-income older methadone users have not been closely examined
from a hermeneutical phenomenological standpoint. Even community gatekeepers tend to
be leery of empirical research endeavors, especially where vulnerable populations are
concerned. For instance, before launching this study, I attempted to gain access to two
major methadone treatment clinics by visiting and talking about the study to the program
directors. Neither was willing to help recruit participants and felt the study was
unnecessary. Despite these roadblocks, I forged ahead and employed a mass marketing
approach, which proved effective.
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Findings from this study further convey implications for professionals working
with older methadone users. Professionals involved with addiction treatment, particularly
methadone, may use this study’s results to develop appropriate treatment interventions
for this population. Although much of previous research about methadone maintenance
treatment focused on dosing and illegal drug use, it is important for treatment providers
to understand how to incorporate various treatment modalities for an older population
dependent on various medications. Findings from the present study validated prior
research findings indicating that older methadone users will need a variety of services to
help ensure they maintain their sobriety and do not return to previous negative behaviors.
In the same vein, findings from the present study can potentially create positive
social change for older methadone users who fail to grasp the need for additional services
and may fall victim to not engaging in other treatment. Collaboration is needed between
treatment providers, funders, and the addiction community so that positive social change
for individuals on methadone may help reduce relapses, criminal justice system
involvement, and increase medical interventions among older methadone users. On an
organizational level, an ongoing working collaboration between treatment programs and
the addiction community may result in service delivery improvement and increase
knowledge regarding stages of change. Finally, relationships between older methadone
users and treatment providers can potentially increase utilization of other services such as
employment and education counseling as well as others as a well-informed provider may
be more willing to refer clients to nonclinical services.
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Conclusion
This hermeneutic phenomenological study’s focus was on examining the lives of
eight methadone users ages 50–55 years who use methadone to address their dependency
on various opiates. These participants shared their private stories and viewpoints for this
study and discussed the issues that caused them to need methadone at their age. Findings
from this study demonstrated that as this population ages there is a need for collaboration
between service providers as older methadone users will need additional services to have
a healthy life. Researchers to date have not adequately studied this population’s
experience in using other treatment modalities besides methadone and the outcomes of
those who have. Study findings showed that older methadone users have unique lived
experiences as they deal with views, attitudes, and barriers in maintaining their sobriety
that need to be further explored and addressed if the field of addiction treatment hopes to
provide quality and relevant care to all those who need such care and seek it out. It was
my goal to provide a different perspective for service providers by giving a voice to older
methadone users.
In spite of life's challenges, study participants have embarked on rebuilding and
reinventing themselves as older methadone users. Taking their recovery slowly, the
participants are progressively redefining their personal values; participants do not want to
review any negative ideas from their past experiences or other people’s beliefs of who
they are or what they should be. Because of their renewed faith in themselves, study
participants have become stronger and more knowledgeable about what methadone will
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do for them. From their lived experiences, participants will hopefully take lessons learned
with them and try to help others understand methadone’s long-term effects.
As agents of social change, counselors and other human service practitioners must
find ways to develop culturally relevant interventions to help older methadone users
continue to make transformative and meaningful changes in their lives. Hopefully,
findings cultivated from the present study will add to the body of knowledge that informs
professional counselors in facilitating the process of growth and change for individuals’
positive change that radiates to families, organizations, and society as a whole.
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Appendix A: Advertisement for Potential Participants

Advertisement for Potential Participants
Let your voice be heard!
Could you be a potential participant dissertation research study?
Who is conducting the study?
LaMart Hightower, a Ph.D. candidate at Walden University for the completion of his
academic work. This facility is not conducting the study and is not responsible for
questions asked, the collection of the material, or its dissemination.
What is the purpose of this study?
The purpose of this study is to assess the relationship between methadone maintenance
and the life experiences of older opiate users, those 50 to 55 years old.
Who is needed for this study?
•

Acknowledge a history of opiate dependency

•

Are between 50 and 55 years old

•

Are currently on methadone to treat their addiction to opiates

•

Have been involved in a license methadone treatment program for the past two

years
•

Have not relapsed within the past year
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In order to CONFIDENTIALLY find out more about this study and possible become a
participant, please email me at lamart.hightower@waldenu.edu or call me at 616-3040149 with your contact information and your preferred means of communication and I
will contact you with details and further information about the study.
Thank you
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Appendix B: Demographic Data Questionnaire

Demographic Data Questionnaire
The title of this study is A hermeneutic phenomenology examination of methadone
treatment and relapse by opiate dependent addicts 50 years and older.
Please complete each of the following demographic items. Thank you for your
participation.
1. Gender (Please check one)
Male____

Female____

2. Age at last birthday________
3. Marital Status (Please check one)
Married____ Divorced____ Widowed____

Single____

4. Please check one
White______ Black or African American____ Hispanic_______
Asian American_________ Other_____ (please specify) ___________________
5. Highest educational level completed (Please check one)
Grade School____

High School____

College Graduate____

Some College____

Graduate or Professional School____

6. As of 2015, how many years have you been on methadone? ________
7. Are you taking methadone to treat an addiction to opiates? Yes_____ No____
8. How long have you been in recovery from opiates? _____________
9.

Are you taking methadone for pain management? Yes___ No____

10. Have your ever received treatment other than methadone for your addiction?
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Yes____

No____

If yes, please identify which treatment (check all that apply)
Residential_____ IOP______ Outpatient______ NA/AA______ Other______
During the time of your sobriety how much of the time have you had any of the
following problems with your work or regular daily activities as a result of your
addiction (such as feeling depressed or anxious)?
All of
the
time

Most of
the time

Some
of the
time

A
little
of the
time

None
of the
time

11. Has your health declined in the
past
five years?

12. Accomplished less than you
would like

13. Did activities decrease

14. During the past year to what extent has your addiction interfered with your
normal social activities with family, friends, neighbors, or groups?
Not at all

Slightly

Moderately

Quite a bit

Extremely

15. Describe your cravings for opiates have you had in the past year?
None

Very
Mild

Mild

Moderate

Severe

Very
Severe

16. During the past year how much has your addiction interfere with your normal life
(including both work outside the home and housework)?
Not at all

Slightly

Moderately

Quite a bit

Extremely
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These questions are about how you feel and how things have been with you
during the past year. For each question, please give the one answer that comes
closest to the way you have been feeling. How much of the time during the past
year.

All of
the time
17. How often has your
health affected your
treatment?

18. Do you have difficulty
making appointments?
19. Do feel like your friends
and family have been
supportive of your
treatment?
20. Have you thought about
using another medical
assisted treatment other
than methadone?

21. During the past year how
much has your addiction
interfered with your social
activities (like visiting
friends, relatives, etc.)?
22. Do you feel like your
treatment plan is working
for you?

Most of Some of
the time the time

A little
of the
time

None of
the time
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Appendix C: Informed Consent
Informed Consent Form
A hermeneutic phenomenological study of methadone treatment by opiate dependent
addicts 50 years and older.
Walden University
You are participating in a research study of opiate users who are maintaining their
recovery with the use of methadone. You are being asked to participate because you met
the inclusion criteria for this study. The inclusion criteria are male or female, between the
ages of 50 to 55 who are involved in a methadone clinic; have been taking methadone for
at least two years; and reside in one of three counties in the state of Michigan, Kent,
Muskegon, and Wayne. Please read this form and ask any questions you may have
before signing this consent form.
This study is being conducted by LaMart Hightower (a PhD candidate at Walden
University).
Background Information:
This study is important in the field of addiction as it increases the understanding
of older opiate users and their lives such as family, medical issues, legal issues, and
relationships. This study will help promote changes through improved understanding of
methadone use for substance abuse therapists.
Procedure:
If you are interested in being in this study, please complete the attached
questionnaire. Completing the questionnaire should take between 5 to 10 minutes. If you
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meet the inclusion criteria, you will participate in an open ended interview which will last
between 60 to 90 minutes. The interview will be audio taped. The researcher will ask
questions regarding your life while using methadone. If you are unsure of the question,
you may ask for clarification or indicate your refusal to answer any questions. Once the
researcher has completed asking you questions, you will be given an opportunity to ask
any questions of your own. If the researcher feels there is a need for follow up questions,
he will inform you of this prior to your leaving and decide on the best way to
communicate such request. The researcher will thank you for your time and discontinue
the recording. It is important to note that you must sign the consent form before the
research can begin to ask any questions.
Voluntary Nature of the Study:
Your participation in this study is strictly voluntary. Your decision whether or not
to participate will not affect your current or future relationship with anyone. If you
initially decide to participate, you are still free to withdraw at any time without affecting
those relationships.
Risks and Benefits of Being in the Study:
In the event you begin to experience stress or possible relapse issues, you may
terminate your participation at any time. You may also refuse to answer any questions
you consider invasive or stressful. In addition, I will provide you with a referral for
services in your community if you began to experience undue stress. In Muskegon
County this will be a referral to Lakeshore Coordinating Agency, Kent County, this will
be a referral to Network 180, and in Wayne County, this will be a referral to Detroit
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Wayne Mental Health Authority. These places will offer a free evaluation and referral to
appropriate treatment programs.
The benefit of participating in this study is to expand information available
regarding opiate dependency, with an emphasis on methadone use among older opiate
users.
Compensation:
Those who are interviewed will receive a $20.00 gift card from Walmart.
Confidentiality:
In order to ensure the confidentiality of the participants only the primary
researcher will know the identities of each of the participants. Each participant will be
given a pseudonym to disguise his or her identity. All paperwork regarding the
participants will be stored in a locked file cabinet that only the primary researcher will
have access to. The researcher will be sure to describe the sample in detail in the
beginning of the study and information pertaining to a particular participant will not have
any identifying information attached to it. All direct quotes that will be used will be
shown to that participant prior to them being included in the study to ensure that the
participant is comfortable with the wording and to give him or her an opportunity to
modify the statement to provide them with sufficient anonymity.
Each of the participants in the study will be given pseudonyms (for example
Participant #1) to prevent identification in reports or results. The key to the match of
pseudonyms and the participant’s real names will be kept at the researcher’s office in a
locked file cabinet. Participants’ real names will only be kept while the data is being
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collected throughout the study and will be separated from any of the data collected.
Likewise, recorded data will be kept in a locked filed cabinet and transcripts will also be
kept separate in a locked file cabinet. University regulations also require that the
principal investigator keep copies of the participant list separate from transcribed data at
his office in a locked file cabinet. The audio recordings of the interviews will be erased
from the voice recorder after the transcripts are completed and checked for accuracy. Per
Walden University’s policy I will maintain all information in a locked file cabinet for five
years after the completion of the study.
I also am aware that the researcher is a mandated reported in the state of Michigan
and is required to report specific incidents to the appropriate authorities. These
incidents include information that may indicate current child abuse or neglect; current
abuse of a vulnerable adult; and/or indications that I am at risk of harming myself or
others.
Contacts and Questions:
The researcher for this study is LaMart Hightower. The researcher’s advisor is Dr.
Barbara Benoliel. You may ask any questions you have now. If you have questions at a
later date, you may contact LaMart Hightower at (616) 304-0149 or email
lamart.hightower@waldenu.edu. The Research Participant Advocate at Walden
University is Dr. Leilani Endicott and you may contact her at 612-312-1210 if you have
any questions about your participation in this study.
You may keep a copy of this consent form.
You will receive a copy of this form from the researcher.
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Statement of Consent:
I have asked questions and have received the answers. I have read the above
information and I agree to participate in the study.
Printed Name of the Participant:

_________________________________

_____

Signature

Date

_________________________________

______

Signature of Investigator

Date
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Appendix D: Script for Recruitment to Participate in In-Depth Interview

Script for Recruitment to Participate in In-Depth Interview
(This script is to be used when meeting with the participant face to face prior to the
interview.
Hello my name is LaMart Hightower. Thank you for your willingness to participate in
my dissertation study entitled “A hermeneutic phenomenological study of methadone
treatment for opiate dependent addicts 50 to 55 years old.”
As you may recall, the purpose of this study is to gain insight into the lives of people 50
to 55 years old who are using methadone to treat their addiction to opiates. The ultimate
goal is to expand on existing help-seeking literature by using yours and other
participants’ experiences and worldviews to shed light on the lived experiences of older
methadone users as it relates to treating their addiction, responding to additional needs,
and understanding the role methadone plays in their lives.
The format of the individual interview is a conversational manner where you would
respond to open-ended questions, describe your experiences, and include your thoughts
and opinions concerning methadone use, your history of addiction, seeking other
assistance, and other issues regarding your recovery.
Once I have completed all initial individual interviews and analyzed them, you and other
participants may be asked to participate in a follow-up interview. The open-ended
questions that will guide the follow-up interview will be developed based on yours and
other participants’ responses from the in-depth interviews.
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All the information collected from you is confidential. Your name or any other
identifying information will not be used in any analysis or in any reporting of the data.
Your participation in this research is completely voluntary. You may decide not to
participate, to withdraw at any time during the interview, or not to answer certain
questions without prejudice or penalty.
May I answer any questions you have?

Thank the participant.

